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ABSTRACT 
 
Total hip arthroplasty is often renowned as one of the most important surgical 
advances of the past century. Orthopaedic surgeons must choose a surgical 
approach to gain access to the hip joint in order to perform the reconstruction. 
There is debate in the literature as to which surgical approach optimizes patient 
outcomes, minimizes complications, and reduces costs to hospitals as a high 
volume procedure. 
 
In the current studies, patient reported outcomes were compared at short-term 
follow-up using a prospective study design across the anterior, posterior, and 
lateral approach. A micro-costing method was used to acquire costs related to 
each procedure, as well as compare hospital metrics such as operating room 
time and hospital length of stay. 
 
The anterior approach demonstrated superior functional outcomes at short-term 
follow-up, and significantly reduced costs from a hospital perspective. Further 
studies should compare objective assessments of function such as gait 
analysis, and cost-effectiveness from a societal perspective. 
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Chapter 1 
 
1 Introduction 
This thesis aims to explore the role surgical approach in total hip arthroplasty 
has on patient reported outcomes and costs of the procedure from a hospital 
perspective. This chapter will review basic anatomy and principles of hip 
arthritis and total hip arthroplasty so that the context of the following chapters is 
clear. The anatomical and technical considerations for the anterior, posterior, 
and lateral approaches to the hip will be reviewed. This will facilitate 
understanding how subtle differences between the three approaches may 
impact clinical results. 
 
1.1 The Hip 
The hip is a ball-and-socket synovial joint formed through an articulation 
between the femoral head and the acetabulum of the pelvis. This articulation 
permits movement through the coronal, sagittal, and transverse planes 1. A 
variety of muscles surround the hip joint, each with their own unique nervous 
innervation and action. The hip joint can be accessed surgically through various 
inter-nervous planes, as well as intra-muscular dissection 2. 
 
1.1.1 Osteology 
The two main bones of the hip include the proximal femur and the bony pelvis. 
The pelvis includes the fusion of three separate bony elements to create the 
acetabulum (Figure 1.1). Each bone has a unique set of bony prominences that 
serve as attachment sites for muscles and ligaments, as well as landmarks for 
planning surgical approaches 1, 2. 
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Figure 1.1 – Osteology of proximal femur and pelvis 
A diagram demonstrating the main bony constituents of the hip joint and bony 
pelvis. The hip joint is represented by the articulation between the femoral head 
and acetabulum (S Petis).  
  3
1.1.1.1 Femur 
The proximal femur consists of four main components – head, neck, and the 
greater and lesser trochanters 3. The femoral head projects in a superomedial 
direction to articulate with the acetabulum 1. The majority of its surface is 
covered with articular cartilage, which allows near frictionless and painless 
range of motion during daily activities such as gait 4. 
 
The greater trochanter is a bony prominence located laterally and posteriorly on 
the proximal femur. The lesser trochanter is a smaller prominence located 
posteromedially at the neck-shaft junction 3. They serve as important landmarks 
during surgical dissection, as well as attachment sites of numerous muscles 
around the hip 1-3. 
 
The neck of the femur forms an angle with the femoral diaphysis of 
approximately 130 degrees in the coronal plane (Figure 1.2). Femoral 
anteversion refers to the angle formed when the femoral neck axis and the 
distal transverse condylar axis are superimposed 1. This angle varies from 8-12 
degrees anterior to the distal transverse condylar axis (Figure 1.3) 4. Femoral 
retroversion occurs when the femoral neck version is directed posterior to the 
transverse condylar axis 1. These angles are important to consider during 
reconstructive procedures such as total hip arthroplasty (THA). 
 
1.1.1.2 Acetabulum 
The acetabulum is the socket of the hip joint. It is formed by the fusion of the tri-
radiate cartilage, which is the growth plate formed by the bony elements of the 
pelvis. These elements include the ischium, ilium, and pubis 1. Approximately 
two-fifths of the acetabulum is contributed by the ilium and ischium, with the 
pubis comprising the remaining fifth. The acetabulum opens laterally, inferiorly, 
and anteriorly 5. The degree of anterior inclination is referred to as acetabular 
anteversion, an angle typically measuring 15-23 degrees (Figure 1.3) 6, 7. 
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The rim of the acetabulum serves as an attachment site for the labrum, a fibro-
cartilaginous structure that deepens the articular surface of the hip joint 5. The 
femoral head is also supported within the acetabulum by the transverse 
acetabular ligament. This structure supports the most inferior aspect of the 
acetabulum, and is a useful landmark for determining acetabular anteversion 
during acetabular reconstructions 6. 
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Figure 1.2 – Femoral neck-shaft angle 
 
The angle subtended by α represents the neck-shaft angle of the proximal 
femur. This angle is normally 130 degrees in the coronal plane. Other important 
bony landmarks such as the greater and lesser trochanters serve as attachment 
sites for muscles and ligaments (S Petis). 
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Figure 1.3 – Version of acetabulum and femoral neck 
 
This axial cross-section of the hip joint demonstrates both acetabular and 
femoral neck version. Acetabular version, represented by angle α, is an angle 
formed by a line along the anterior and posterior aspect of the acetabulum 
intersecting a line in the sagittal plane. Normally, the acetabulum opens 
anteriorly, as demonstrated in this diagram, which is referred to as anteversion. 
If the acetabulum opens posteriorly, this is referred to as retroversion. Normal 
acetabular version is 15-23 degrees of anteversion. Femoral neck version, 
represented by angle Σ, is an angle formed by a line along the axis of the 
femoral neck and the distal transverse condylar axis of the knee. This angle is 
normally 8-12 degrees of femoral anteversion (S Petis).
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1.1.2 Musculature around the hip 
 
There are several muscles that surround the hip joint. Each muscle has its own 
bony or soft tissue origin and insertion, as well as nervous innervation. The 
nervous innervation of each muscle creates inter-nervous planes that are 
essential to understand when dissecting around the hip joint 2. 
 
1.1.2.1 Sartorius 
The sartorius is the longest muscle in the body. It originates off the anterior-
superior iliac spine of the pelvis, and inserts on the proximal tibia as part of the 
pes anserine group. It is a weak hip flexor and external rotator, as well as a 
weak knee flexor and internal rotator 1. It is innervated by the femoral nerve and 
serves as an important muscle during superficial dissection when using the 
anterior approach to the hip 8. 
 
1.1.2.2 Tensor fascia latae 
The tensor fascia latae is a more laterally based muscle originating from the 
anterior-superior iliac spine and inserting onto the iliotibial band. It assists in 
abduction, flexion, and internal rotation of the hip 1. Innervated by the superior 
gluteal nerve, it forms a superficial inter-nervous plane with sartorius during the 
anterior approach to the hip 9. 
 
1.1.2.3 Rectus femoris 
The rectus femoris is a member of the quadriceps femoris group innervated by 
the femoral nerve. It is the only muscle in the group to cross both the hip and 
knee joints. This allows the muscle to contribute to flexion at the hip, and 
extension at the knee 1. The muscle originates via a direct and indirect head; 
the direct head comes off of the anterior-inferior iliac spine, while the indirect 
head originates from the superior rim of the acetabulum and the anterior joint 
capsule (Figure 1.4) 1, 2. This is important during an anterior approach to the 
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hip, as both the direct and indirect head are retracted to improve visualization of 
the femur and acetabulum during reconstructive procedures 9-11. 
 
1.1.2.4 Gluteus medius 
The gluteus medius is a large, fan-shaped muscle often referred to as the 
“rotator cuff” of the hip 12. It originates from the ilium between the anterior and 
posterior gluteal lines, splits into anterior, middle, and posterior portions, and 
inserts into two facets on the greater trochanter 1, 13. Each portion of the gluteus 
medius is innervated by a branch of the superior gluteal nerve 12. This muscle 
initiates hip abduction, produces subtle pelvic rotation to optimize gait 
efficiency, and helps stabilize the femoral head within the acetabulum during 
weight bearing 12, 14. It is important to understand the anatomic boundaries of 
this muscle during a lateral approach to the hip 15. 
 
1.1.2.5 Gluteus maximus 
The gluteus maximus is a large muscle originating from the sacrum, ilium, and 
thoracolumbar fascia. It has upper and lower fibers inserting on the iliotibial 
band and gluteal tuberosity, respectively. This muscle is a powerful hip extensor 
and external rotator 1. Innervated by the inferior gluteal nerve, many of the 
muscle fibers of gluteus maximus are split during a posterior approach to the 
hip 2. 
 
1.1.2.6 Short external rotators 
The group of muscles commonly referred to as the short external rotators 
includes piriformis, obturator internus, and the superior and inferior gemelli 
muscles (Figure 1.5). They originate from various bony landmarks including the 
sacrum, ischial spine and tuberosity, and the obturator foramen 1. The gemelli 
form a conjoint tendon with obturator internus to insert on the medial aspect of 
the greater trochanter, whereas piriformis inserts at the apex of the greater 
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trochanter 1, 2. These muscles receive their nervous innervation from small 
branches of the sacral plexus, and they are weak contributors to hip external 
rotation. They are important landmarks during the posterior approach to the hip, 
and are often used to help identify and protect the sciatic nerve during this 
approach 2. 
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Figure 1.4 – Anterior muscles of the hip 
 
There are several important muscles crossing the anterior aspect of the hip 
joint. These muscles form important inter-nervous planes that allow the surgeon 
to access the hip joint safely. The sartorius and tensor fascia latae form the 
superficial inter-nervous plane for an anterior approach to the hip. The rectus 
femoris forms the deep inter-nervous plane of the anterior approach with the 
gluteus medius. Note the two tendinous insertions of the rectus femoris (S 
Petis). 
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Figure 1.5 – Posterior muscles of the hip 
 
This diagram depicts many muscles that cross the hip posteriorly and laterally. 
The tendinous insertion of the gluteus medius is split during a lateral approach 
to the hip. The superior and inferior gemelli and obturator internus form a 
conjoint tendon that is dissected off the proximal femur with the piriformis during 
a posterior approach to the hip (S Petis). 
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1.2   An overview of hip arthritis 
 
The purpose of this section is to provide a brief overview of hip arthritis, its 
clinical features, and non-arthroplasty forms of treatment. The discussion will 
then describe total hip arthroplasty and its impact on patient outcomes. This will 
help demonstrate how the various surgical approaches to the hip can impact 
clinical outcomes. 
 
1.2.1 Hip arthritis 
Arthritis is a degenerative pathologic condition of the articular cartilage of 
synovial joints 16. Damage and loss of articular cartilage leads to 4 cardinal 
changes within the joint: joint space narrowing, osteophytosis, subchondral 
bony sclerosis, and subchondral cyst formation (Figure 1.6) 17. These changes 
cause debilitating musculoskeletal pain and psychological distress to those who 
have to live with the disease 18.  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 
The top image is an anterior
bottom image is an anterior
the cardinal signs of arthritis on the bottom radiograph: joint space narrowing, 
osteophyte formation, subchondral sclerosis, and cyst formation (S
 13 
– The normal and arthritic hip joint
-posterior radiograph of a normal hip joint. The 
-posterior radiograph of an arthritic hip 
 
 
joint. Note 
 Petis). 
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1.2.1.1 Etiologies 
Osteoarthritis is the most common cause of arthritis of the hip joint 16. Primary 
osteoarthritis, or idiopathic arthritis, refers to cases where the cause of joint 
degeneration is unknown. Cases where there is an identifiable cause for the 
degenerative process are referred to as secondary osteoarthritis 19. Several risk 
factors have been identified that may contribute to the development of 
osteoarthritis. Systemic factors include increased age, female sex and estrogen 
deficiency, increased bone density, poor nutrition, and genetics. Biomechanical 
risk factors include obesity, previous joint trauma, congenital joint deformities, 
certain vocations such as farming, sports participation, and surrounding muscle 
weakness 17, 20. Other contributing factors include femoroacetabular 
impingement (FAI), developmental hip dysplasia, and slipped capital femoral 
epiphysis, although the details of each are beyond the scope of this discussion 
16, 21, 22
. 
 
Other causes of joint degeneration within the hip are related to biological 
processes causing damage to the hyaline articular cartilage. Generally, these 
conditions expedite the degenerative process and cause much earlier 
debilitating pain and functional limitations 16. Osteonecrosis of the femoral head, 
also known as avascular necrosis, is the result of ischemia to the subchondral 
bone, causing collapse of the supportive bony architecture and accelerated 
cartilage damage due to altered biomechanical stresses 23. Legg-Calvé-Perthes 
disease is the childhood variant of idiopathic femoral head ischemia and 
necrosis leading to degenerative changes later in life 24. Inflammatory arthritides 
are another cause of hip arthritis, examples of which include rheumatoid 
arthritis, ankylosing spondylitis, and systemic lupus erythematosus 16. Joint 
destruction results from an aggressive inflammatory process driven by an 
autoimmune response to host biomarkers 25. Finally, rapid and profound 
articular cartilage destruction is the devastating sequelae of untreated septic 
arthritis 26. All of these conditions must be considered when consulting a patient 
regarding hip arthritis (Figure 1.7). 
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Figure 1.7 – Etiologies of hip arthritis 
 
Several different factors contribute to the degenerative changes manifested as 
hip arthritis. The most common is primary, or idiopathic osteoarthritis. All other 
etiologies should be considered when acquiring a history from a patient with hip 
pain (S Petis). 
Hip Arthritis 
Primary Osteoarthritis 
Secondary Osteoarthritis: 
- Osteonecrosis 
- Legg-Calve-Perthes disease 
- Femoroacetabular impingement 
- Hip dysplasia 
- Slipped capital femoral epiphysis 
Joint Sepsis 
Trauma 
Genetics 
Systemic Factors: 
- Advanced age 
- Female sex 
- Poor nutrition 
Biomechanical Stress: 
- Obesity 
- Neuromuscular 
dysfunction 
- Vocation 
- Joint deformity 
Inflammatory Arthritis 
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1.2.1.2 Clinical features of hip arthritis 
Patients presenting with hip arthritis will have a number of clinical features 
unique to this disease. The patient will often complain of groin pain, buttock 
pain, or pain around the greater trochanter 27. The patient will often cup their hip 
with their hand when asked to locate the pain, which is known as the “C” sign. 
The pain may radiate to the inside of the knee due to irritation of the saphenous 
branch of the femoral nerve 28. The pain is usually worse with activity, and 
abates with rest. Patients report that activities of daily living such as walking 
and self-hygiene have become cumbersome. Other associated symptoms 
include stiffness, joint instability, and motor weakness. Careful questioning 
should determine that the pain in the hip is not due to radiating patterns from 
the spine and knee as well 29. 
 
A detailed physical examination is essential in confirming the diagnosis, and 
eliciting findings that may impact future reconstructive procedures 27. Physical 
examination should begin by observing the patient’s gait. A Trendelenburg gait 
and sign is a common physical finding resulting from abductor weakness 14. The 
hip should be fully exposed to examine for bruising, swelling, erythema, or 
previous surgical scars. The examiner should note any leg length discrepancy 
that may impact future reconstructive procedures 27. Range of motion and 
strength testing should document any limitations. Patients with hip arthritis 
typically have reduction in internal rotation and abduction, with pain in the groin 
elicited with internal rotation 29. Pain produced in the groin with an active 
straight leg raise is often associated with hip arthritis, which is known as the 
Stinchfield test 30. A complete neurovascular examination is critical to compare 
to any potential post-operative changes. Again, examination of the spine and 
knee are essential to ensure that the true source of functional limitation and 
pain is originating from the hip. 
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1.2.1.3 Epidemiology of hip arthritis 
Hip arthritis has a tremendous impact on patient quality of life and level of 
functioning. By the year 2020, the World Health Organization projects that 
osteoarthritis is expected to become the 4th leading contributor to patient 
disability 31. A recent systematic review suggests a prevalence of 10.9% for hip 
osteoarthritis for all-comers 32. This prevalence differs for different countries 
around the world, as well as whether a clinical or radiographic definition is used 
to diagnose osteoarthritis 33. Health care systems incur tremendous costs while 
patients live with debilitating hip arthritis. This is particularly true when patients 
are waiting for joint replacement surgery, a time when health related quality of 
life and functionality are presumed to be the lowest 34, 35. As populations 
continue to live longer, more people will live with chronic disease such as 
arthritis, creating increased demand for both non-surgical and surgical modes of 
treatment 33. 
 
1.2.1.4 Treatment of hip arthritis – Non-surgical 
There are a variety of non-surgical treatment modalities available to mitigate the 
pain associated with arthritis. Treatment of hip arthritis should be tailored to 
patients’ symptoms and previous therapies. Initially, treatment should begin with 
less invasive options and progress towards surgical intervention 29.  
 
Early non-operative management includes exercise therapy. This has been 
shown to reduce pain early following the diagnosis of hip arthritis, and can 
contribute to weight-loss and muscle strengthening 36. Weight-loss has been 
shown to reduce disability associated with osteoarthritis 37. The use of a gait aid 
such as a cane or a walker can help produce an abductor moment to off-load 
the affected hip, particularly in the setting of abductor insufficiency. Patients 
may also need to avoid activities that exacerbate their hip pain, which 
sometimes includes taking time off of work if the individual is employed. 
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After these measures have failed, pharmacotherapy can effectively control pain 
associated with osteoarthritis. A Cochrane review has demonstrated that 
acetaminophen is better than placebo at controlling pain associated with 
osteoarthritis. Non-steroidal anti-inflammatory drugs (NSAIDs) may be more 
effective than acetaminophen at controlling painful osteoarthritis; however, 
there is an increased risk of gastrointestinal side effects, hypertension, and 
renal dysfunction with prolonged NSAID use 38. Corticosteroid and visco-
supplementation injections are also treatment options 29. These injections are 
usually performed under radiographic or ultrasonographic guidance when used 
to treat painful osteoarthritis of the hip. Studies have demonstrated reduced 
pain and less reliance on other medications such as NSAIDs following visco-
supplementation 39, 40. 
 
1.2.1.5 Treatment of hip arthritis – Surgical 
There are a number of surgical procedures available to treat patients with 
painful hip arthritis once non-surgical methods have become ineffective. Within 
the realm of surgical procedures, a number of non-arthroplasty options must be 
considered. Total hip arthroplasty will be discussed in greater detail in the 
following section. 
 
Hip arthroscopy has become a popular procedure in the setting of the painful 
hip. Its utilization has steadily increased over the past decade as both a 
diagnostic and therapeutic procedure 41. In the literature, indications include 
removal of intra-articular loose bodies, osteochondroplasty for painful 
impingement associated with FAI, grading the degree of articular cartilage 
degeneration, labral repair, synovectomy, irrigation of septic arthritis, extra-
articular tendon releases, and debridement for osteoarthritis 16, 42. However, 
there is a paucity of literature documenting the clinical efficacy of hip 
arthroscopy in treating pain due to hip arthritis at long-term follow-up. Therefore, 
managing patient expectations is very important when considering this surgical 
procedure 41. 
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Other surgical considerations are used for specific circumstances. The peri-
acetabular osteotomy as described by Ganz can manage painful hip arthritis 
and limit the progression of degeneration in patients with mild to moderate 
acetabular dysplasia 43. Proximal femoral osteotomies can correct deformities 
that create accelerated wear on articular cartilage from increased 
biomechanical stresses. Valgus- or varus-producing osteotomies, derotation 
osteotomies, and shortening osteotomies are used in conditions such as 
developmental dysplasia of the hip, Legg-Calve-Perthes disease, slipped 
capital femoral epiphysis, or post-traumatic arthritis 16, 27. Hip arthrodesis, or 
fusion, is largely a historical procedure reserved for young patients with severe 
hip arthritis in order to delay the need for a reconstructive procedure (Figure 
1.8) 16.  
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Patient diagnosed with hip arthritis 
Non-operative treatment: 
- Weight loss 
- Exercise 
- Activity modification 
- Gait aid 
Pharmacotherapy: 
- Acetaminophen 
- NSAIDs 
- Injections 
Surgical considerations in 
young patient or specific 
diagnosis (i.e. FAI): 
- Hip arthroscopy 
- Periacetabular  / 
femoral osteotomy 
- Hip arthrodesis 
Failed non-surgical 
modalities or other 
surgical interventions: 
- Total hip 
arthroplasty 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 – Treatment algorithm for hip arthritis 
 
This diagram represents a treatment algorithm for hip arthritis. Patients undergo 
a trial of non-operative management modalities such as gait aids and 
pharmacotherapy. If these fail, the treating surgeon considers surgical 
management tailored to each patient’s underlying pathology (S Petis).  
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1.2.2  Total hip arthroplasty 
Since its inception in the late 1950s, THA has revolutionized the treatment of 
painful hip arthritis 44. The main constituents of the surgical reconstruction 
include a femoral stem, acetabular shell, and bearing articulation. This section 
will briefly outline the technical aspects of the procedure, as well as its clinical 
efficacy in the literature.  
 
1.2.2.1 Femoral reconstruction 
The goal of THA is to reproduce the native center of rotation of the femoral 
head 27. This involves inserting a metal femoral stem into the proximal femur 
(Figure 1.9). The reconstruction begins by exposing the proximal femur through 
the chosen surgical approach. The femoral head is then dislocated from the 
acetabulum in a controlled manner. This will provide the surgeon with 
visualization of the femoral head, neck, and greater and lesser trochanters 16, 27. 
 
Once the femoral neck is exposed, an oscillating saw is used to perform an 
osteotomy of the femoral neck. The location of this osteotomy is dependent on 
careful pre-operative templating 16. Generally, this osteotomy is performed 
approximately 1 centimeter above the lesser trochanter, and perpendicular to 
the long axis of the femoral neck 45. This will allow the surgeon to prepare the 
femoral intramedullary canal to receive the femoral stem implant. 
 
The intramedullary canal is prepared using a series of graded reamers and 
broaches. These instruments are passed down the canal, and the broaches are 
often used as trial implants to represent the appropriately sized femoral implant. 
With the broach in-situ, a trial femoral head is placed on the neck of the femoral 
implant and reduced into a reconstructed acetabulum. This is when the surgeon 
decides to ask for the definitive implants, or make adjustments based on the 
following principles. 
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It is important that the surgeon matches the patient’s femoral anteversion while 
broaching to prevent instability and impingement associated with an overly 
anteverted or retroverted implant 46. The surgeon must be cognizant of the 
depth the femoral stem is implanted in order to maintain leg length equality and 
tensioning of the surrounding soft tissue including muscles and ligaments 27. 
Soft tissue tensioning is also impacted by femoral offset, which is the distance 
from the center of the femoral head to the center of the femoral canal 47. 
Restoring these anatomic variables will produce more efficient gait mechanics 
and limit excess biomechanical stresses across the implant 27.  
 
Finally, the surgeon must then choose whether to use a cemented or 
cementless femoral stem. Cemented femoral stems are placed into a 2-4 
millimeter polymethylmethacrylate polymer mantle that acts as a grouting 
material to interdigitate with the host bone 48, 49. They are generally smooth, 
highly polished stems with no sharp edges to limit de-bonding from the cement 
mantle 50. This form of fixation has several indications including profound 
osteopenia, irradiated bone, and unusual proximal femoral anatomy 27. 
Cementless femoral stems rely on biological bony in-growth into a porous 
coating or bony on-growth onto a grit-blasted or hydroxyapatite surface 27, 51-53. 
They are an attractive option because there is no need to use cement intra-
operatively, resulting in shorter surgical times and reducing the theoretical risk 
of intra-operative hypotension caused by pressurizing cement into the femoral 
canal 54, 55. Regardless of the mode of fixation, many femoral stems have 
excellent survivorship and clinical outcomes at long-term follow-up 56-61. 
  
  
 
 
 
 
 
 
 
 
This is an example of the Corail 
IN), a femoral stem used to reconstruct the proximal femur. It is an example of a 
cementless, hydroxyapatite
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Figure 1.11 – Femoral stem 
 
Figure 1.9 – Femoral stem 
 
TM stem (DePuy Orthopaedics Inc., Warsaw, 
-coated stem (S Petis). 
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1.2.2.2 Acetabular reconstruction 
 
Acetabular reconstruction is the second constituent of a THA. As with femoral 
reconstructions, the goal of reconstructing the acetabulum is to reproduce the 
anatomic center of rotation to enable functional range of motion and stability 16, 
62-64
. Pre-operative radiographs are useful in planning the positioning of 
acetabular component, as adequate medialization of the component to the 
acetabular floor limits biomechanical stresses and early implant failure 64, 65. 
 
In order to ensure proper component positioning, the acetabulum must be 
adequately exposed through the chosen surgical approach 16, 27. Surrounding 
soft tissue including joint capsule, labrum, and osteophytes are removed from 
the rim of the acetabulum. Acetabular reamers are then used to prepare the 
floor of the acetabulum to accept the acetabular implant. The size of the reamer 
incrementally increases until the size of the last reamer engages the anterior-
posterior extent of the native acetabulum 27. Throughout reaming, the surgeon 
is able to control the version and inclination of the acetabular reconstruction. 
Bony landmarks as well as soft tissue structures are used to assist the surgeon 
in reproducing anatomic acetabular anteversion 63, 66, 67. Inclination is re-created 
by visualizing the position of the final reamer relative to the floor of the 
operating room, as well as a cup positioner or guide that accompanies many 
total hip implant systems 68, 69. Acetabular inclination between 35-45 degrees 
has been shown to optimize range of motion, limit impingement on the femoral 
component, and lower the risk of hip dislocation 63, 70, 71. As with femoral 
reconstructions, trial implants are available to allow the surgeon to reduce the 
reconstructed hip and assess range of motion and stability before definitive 
implant selection 27, 68, 69. 
 
Once the surgeon is satisfied with the trial reconstruction, the definitive 
acetabular shell is chosen. Current generation acetabular shells are fabricated 
from titanium and are porous coated 16. The porous coating allows biological 
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bony in-growth that permits implant fixation. Once the shell is in-situ, several 
shell manufacturers allow for the insertion of screws to augment fixation into the 
bony pelvis 68, 69. The decision to insert screws is based on the surgeon’s 
assessment of the patient’s bone quality and bony contact with the shell, co-
morbid conditions that may preclude quality bony in-growth such as 
inflammatory arthropathy, and osteopenia 72, 73. Current generation acetabular 
shells provide reliable long-term fixation and excellent clinical outcomes 74-76.  
 
1.2.2.3 Bearing articulations 
Once the femoral and acetabular reconstructions are complete, a bearing 
articulation must be chosen. Bearing articulations are composed of a femoral 
head, which attaches to the femoral stem via a Morse taper, and an articulating 
liner, which sits inside the acetabular shell. There are several options available 
when choosing a bearing articulation, each with theoretical advantages and 
disadvantages. 
 
The acetabular liner can include polyethylene, ceramic, or metal 16. 
Polyethylene is a plastic that is the most utilized lining surface in total hip 
arthroplasty 77. The most concerning feature of polyethylene use is wear, 
resulting in particulate matter that causes phagocytosis of bone, osteolysis, and 
implant loosening 78, 79. Biomedical engineers have constantly modified how 
polyethylene is manufactured in order to reduce wear and improve the longevity 
of the plastic. This includes sterilization in inert atmospheres such as ethylene 
oxide or gas plasma, re-melting versus annealing, and exposing the 
polyethylene to radiation 80. Radiation has been shown to induce cross-linking 
at the molecular level, which improves the wear resistance of the plastic 81. This 
has lead to improved wear resistance in-vivo with at least intermediate follow-up 
82-84
. 
 
Metal is another consideration as an acetabular lining material. In simulator 
studies, metal has improved wear resistance over polyethylene 85, 86. Metal is 
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also less brittle compared to ceramic, reducing the risk of implant fracture 87. 
However, studies have demonstrated that metal bearings can increase the 
generation of chromium and cobalt ions, which can leach into human serum 
and be excreted in urine 88, 89. This may induce a T-cell mediated lymphocytic 
reaction referred to as an atypical lymphocytic vasculitis-associated lesion. 
These lesions may result in aseptic loosening and failure of metal-on-metal 
arthroplasties 90. Pseudotumors are a localized granulomatous reaction to metal 
ions that can cause inflammation, pain, and the need for revision surgery for 
patients with metal-on-metal articulations 91. Although there are concerns 
regarding increased carcinogenesis risk, nephrotoxicity, and neurotoxicity 
associated with elevated metal ion levels, these presumptions are poorly 
supported in the literature 79, 92, 93. 
 
Ceramic was introduced as an acetabular liner in the 1970s 94. The material has 
undergone several generational changes, resulting in a contemporary alumina 
composite material 95. The advantages of ceramic materials are that they are 
extremely hard and scratch resistant, which amounts to reduced wears rates 
compared to other articulating bearings 96-98. Ceramic also exhibits good 
biological inertness, reducing localized soft tissue reactivity 99. The main 
disadvantages of ceramic materials are the risk of fracture due to increased 
brittleness, and squeaking due to edge loading in-situ. The risk of implant 
fracture has lessened significantly with the introduction of tougher alumina 
composites 94. Edge loading and resultant squeaking are caused by poor 
component positioning, inability to restore leg-lengths and femoral offset, and 
implant impingement 100, 101. Careful surgical technique can therefore ameliorate 
the risk of squeaking. 
 
Once the acetabular liner has been chosen, the surgeon is left to choose a 
femoral head to articulate with the liner. Three main femoral head materials 
exist: metal, which is usually made from a cobalt chromium alloy, ceramic, and 
oxidized zirconium. Cobalt chrome is a long-standing femoral head bearing with 
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the advantage of modularity, or availability of different implant specifications 
that allow the surgeon to better customize their reconstruction during THA 102. 
Ceramic has demonstrated reduced wear rates when compared to cobalt 
chrome, both in simulation and clinical studies 103, 104. However, the retained 
fragments of a fractured ceramic head can cause accelerated polyethylene 
wear, metallosis, and damage to the Morse taper located on the femoral stem 
(Figure 1.10) 105, 106. Oxidized zirconium is a newer material composed of a 
metallic alloy center and an oxidized zirconium surface. It was designed to 
retain the exceptional wear rates seen with ceramic bearing surfaces, but 
reduce the risk of implant fracture 94. Early clinical follow-up suggests reduced 
wear when compared to cobalt chromium 107. This section clearly outlines the 
number of implant options available to the surgeon and the complexities of 
choosing the right combination of implants for each individual patient. 
Figure 1.10
The femoral head is engaged onto the femoral stem through a Morse taper. The 
femoral head is carefully seated on the femoral neck, followed by the surgeon 
impacting the head with a 
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 – Assembled femoral stem and head
 
mallet to engage the taper (S Petis). 
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1.3 Surgical approaches for total hip arthroplasty 
There are a variety of surgical approaches available to access the hip joint 
when performing a THA. Each approach demands a thorough understanding of 
human anatomy in order to optimize femoral and acetabular visualization, and 
minimize complications. This section will briefly outline the technical aspects of 
the anterior, lateral, and posterior approach, as well as a concise discussion of 
associated risks and benefits for each approach. A literature review will outline 
how the different approaches may impact patient outcomes and function 
following THA. 
 
1.3.1 Anterior approach to the hip 
The anterior approach to the hip was first described by Smith-Peterson in the 
1940s and was later modified by Heuter in the 1950s 11. In Canada, it is an 
approach utilized by less than 5 percent of orthopedic surgeons performing 
THA 108. Advocates of this approach identify muscle-sparing intervals, earlier 
restoration of gait kinematics, and low dislocation rates as its main advantages 
8, 109-112
. The anterior approach can be performed with and without the use of a 
specialized table 9, 10. The use of a specialized table will be described in this 
section. 
 
1.3.1.1 Anatomy and technical considerations 
The procedure begins by positioning the patient supine on a specialized 
operating room table (Figure 1.11). Both feet are firmly secured to boots that 
are attached to lever arms that permit the application of traction to either limb. 
There is also a perineal post located between the legs that stabilizes the patient 
on the operating room table, and provides a point of counter-traction 9. 
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Figure 1.11 – Anterior approach traction table 
 
An example of a traction table (Hana TM fracture table, Mizuho OSI, Union City, 
CA) used for the anterior approach. Both legs are securely fastened in the 
boots provided, where traction, rotation, and angular motion can be applied to 
both limbs (S Petis). 
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The surgical incision begins just lateral to the anterior superior iliac spine of the 
pelvis. It is then carried distally for approximately 8 centimeters towards the 
patient’s knee (Figure 1.12). The lateral femoral cutaneous nerve is identified, 
transposed medially, and protected. A plane is then developed between the 
tensor fascia latae and sartorius. The surgeon will then encounter the interval 
between rectus femoris and gluteus medius. The rectus femoris is retracted 
medially, and the gluteus medius is retracted laterally to expose the anterior 
joint capsule of the hip. The joint capsule is then incised along the length of the 
femoral neck from the acetabulum to the intertrochanteric line. Once traction is 
applied to the operative limb, external rotation can be used to dislocate the 
femoral head from the acetabulum 2, 9. 
 
Once the femoral head is dislocated, a femoral neck osteotomy is performed at 
the desired level based on pre-operative planning. The femoral neck osteotomy 
can also be performed in-situ prior to dislocating the hip with careful soft tissue 
retraction. Intra-operative fluoroscopy is used during acetabular reaming to 
ensure adequate restoration of anteversion and inclination. Femoral preparation 
can be difficult due to limited proximal femoral exposure with this approach. The 
operative limb is generally placed in a position of extension, adduction, and 
external rotation in order to improve the accessibility of the proximal femur. 
Again, intra-operative fluoroscopy is used to help the surgeon determine 
accurate preparation of the femoral canal in order to restore version and offset 
(Figure 1.13). Once the final implants are in-situ and the hip is reduced, implant 
positioning is verified with fluoroscopy and the stability of the construct is 
assessed out of traction 2, 9, 10. 
 
Figure 1.12 
An intra-operative photograph of the skin incision used for the anterior 
approach. The incision starts at the anterior superior iliac spine and heads 
towards the lateral aspect of the patient’s knee. A perineal p
secure both limbs to the traction table and provide a point of counter
Petis).
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Figure 1.13 – Fluoroscopic C-arm 
 
The fluoroscopic C-arm is a device used to attain x-rays during a surgical 
procedure. Many surgeons utilize intra-operative fluoroscopy during an anterior 
total hip arthroplasty in order to verify the position of the acetabular and femoral 
component (S Petis). 
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1.3.1.2 Risks of the anterior approach 
 
There are risks associated with every surgical approach. Commonly cited risks 
of the anterior approach include proximal femur fractures, wound complications, 
lateral femoral cutaneous nerve palsies, and prolonged operative time due to 
the technically demanding nature of the procedure. Jewett and Collis reviewed 
800 THAs performed through an anterior approach. They sited 19 
intertrochanteric fractures (2.3%), 7 post-operative dislocations (0.88%), and 37 
wound complications (4.6%). Most of the intertrochanteric fractures occurred 
during preparation of the femoral canal. Wound complications were attributed to 
the location of the incision, which is close to the groin area 113.  
 
Another study by Woolson and colleagues retrospectively reviewed 247 THAs 
performed through an anterior approach in a community hospital. In 6.5% of 
cases there was an intra-operative proximal femur fracture. They also reported 
that 21% of cases had acetabular inclination angles greater than 50 degrees 
despite the use of intra-operative fluoroscopy 114. This study, as well as results 
reported in a small series by Spaans et al., suggests longer operative time and 
increased blood loss associated with the anterior approach 114, 115. However, 
these findings are likely related to surgeon experience, as Matta et al. reported 
much shorter operative time and less blood loss in 437 patients having an 
anterior approach 8.  
 
Finally, neurpraxia of the lateral femoral cutaneous nerve can occur in up to 
67% of patients having a THA through an anterior approach 116. This is due to 
the nerve’s variable course around the anterior superior iliac spine, and as it 
crosses the sartorial-tensor fascia latae plane more distally 2, 8. Most of these 
neuropraxic injuries resolve without any long-term sequelae 8, 111. 
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1.3.2 Lateral approach to the hip 
The lateral approach to the hip was described by Hardinge in the 1980s 15. 
Approximately 60% of Canadian orthopedic surgeons perform THAs using a 
lateral approach 108. This approach provides excellent exposure of both the 
proximal femur and acetabulum during reconstructive procedures 2. A very low 
dislocation rate has also been reported in clinical follow-up 117, 118.  
 
1.3.2.1 Anatomy and technical considerations 
The procedure begins by positioning the patient in either the left of right lateral 
decubitus position for a right or left THA, respectively. The operative limb is 
draped freely to assist with dislocating the hip in order to expose the proximal 
femur and acetabulum. A longitudinal incision is made extending 3-5 
centimeters proximal and approximately 5-8 centimeters distal to the tip of the 
greater trochanter (Figure 1.14). The fascia of the tensor fascia latae and 
gluteus maximus is then split in line with the skin incision. The surgeon will then 
encounter the tendon and muscle fibers of gluteus medius. These muscle fibers 
are split at the midway point between the most anterior and posterior extent of 
the muscle. The split is carried distally, leaving a cuff of gluteus medius tendon 
for repair following the procedure. The surgeon then incises the gluteus 
minimus and joint capsule overlying the neck of the femur. At this point, the 
surgeon is then able to dislocate the femoral head by externally rotating and 
flexing the hip. With the hip joint dislocated, the surgeon then performs a 
femoral neck osteotomy. This will provide the required exposure to complete 
both the femoral and acetabular reconstructions 2, 15. 
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Figure 1.14 – Skin incision for the lateral approach 
 
An intra-operative photograph of the skin incision used for the lateral approach. 
The patient is positioned in the left lateral decubitus position in preparation for a 
right total hip arthroplasty (S Petis). 
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1.3.2.2 Risks of the lateral approach 
As with the anterior approach, the lateral approach has its own associated risks. 
These include abductor muscle insufficiency and a nerve palsy of the superior 
gluteal nerve or femoral nerve. 
 
Abductor muscle insufficiency is a common clinical scenario following a lateral 
approach. It can cause abductor muscle weakness, a Trendelenburg gait or 
sign, inefficient gait mechanics, and peritrochanteric pain 14, 117, 119, 120. The 
insufficiency likely results from an inadequate repair following a lateral 
approach, chronic degeneration of the gluteus medius tendon pre-operatively, 
or irreparable tears at the time of THA in up to 20% of patients undergoing THA 
121, 122
. Masonis and Bourne reviewed over 2400 THAs having a lateral 
approach for THA and reported an incidence of 4-20% for abductor insufficiency 
post-operatively 117. 
 
A superior gluteal or femoral nerve palsy is another potential complication 
following a lateral approach to the hip. The superior gluteal nerve passes 
between the gluteus medius and minimus muscles approximately 5 centimeters 
proximal to the greater trochanter 2. Retrospective and prospective studies 
suggest an incidence of 2.2-42.5% for superior gluteal nerve injuries following 
reconstructive hip procedures using a lateral approach 123-125. This nerve palsy 
can lead to abductor insufficiency and poorer functional outcomes following 
THA; fortunately, many cases improve spontaneously 125. The femoral nerve is 
at risk with over-rigorous placement of soft tissue retractors over the anterior 
aspect of the acetabulum 2. A study by Mulliken et al. did not identify any 
femoral nerve injuries in 770 consecutive lateral approaches to the hip 126. The 
highest reported rate of femoral nerve palsy using a direct lateral approach was 
by Simmons and colleagues. They had 10 palsies in 440 hips with all cases 
having full functional recovery at 1 year post-operatively 127. 
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1.3.3 Posterior approach to the hip 
The posterior approach to the hip was popularized by Moore in the 1950s 2. A 
recent survey of surgeons from around the world suggests that the posterior 
approach is the most common surgical approach for THA internationally 128. In 
Canada, approximately 36% of arthroplasty surgeons utilize the posterior 
approach 108. It provides excellent visualization of both the acetabulum and 
femur during both primary and revision reconstructive procedures. The 
approach also spares the abductor muscles during surgical exposure of the 
acetabulum and femur 2. 
  
1.3.3.1 Anatomy and technical considerations 
Similar to the lateral approach, the patient is usually placed in the left or right 
lateral decubitus position. Again, the involved limb is draped freely to facilitate 
dislocating the hip, and to permit maneuverability of the limb to improve 
visualization throughout the case. The skin incision begins approximately 6 
centimeters proximal and slightly posterior to the posterior aspect of the greater 
trochanter. The incision curves towards the greater trochanter and then extends 
down the femoral diaphysis for another 5 centimeters (Figure 1.15). The 
surgeon then incises the fascia overlying gluteus maximus and bluntly splits this 
bulk of muscle down to the short external rotators. The sciatic nerve is often 
draped over the short external rotators encased in adipose tissue. This 
structure must be carefully protected throughout this approach. The short 
external rotators and piriformis are then dissected off their insertion onto the 
greater trochanter. This will then expose the posterior joint capsule, which is 
incised to reveal the femoral neck and head. The surgeon is then able to 
dislocate the hip and begin the reconstruction 2. 
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Figure 1.15 – Skin incision for the posterior approach 
An intra-operative photograph of the skin incision used for the posterior 
approach to the hip. The patient is positioned in the lateral decubitus position. 
The incision curves posteriorly proximal to the greater trochanter. Alternatively, 
the incision can be made longitudinally with the hip flexed to 90 degrees (S 
Petis). 
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1.3.3.2 Risks of the posterior approach 
A unique risk profile also exists for the posterior approach. Post-operative 
dislocations of the hip joint are a concern due to disruption of the posterior joint 
capsule 129. By virtue of its proximity to the short external rotators, the sciatic 
nerve is vulnerable to injury during this approach 2. These are the most 
commonly feared complications of the posterior approach. 
 
The rate of hip dislocations following THA has been extensively studied. In the 
literature, reported dislocation rates vary anywhere between 1-5% 118, 130-133. 
The reason for the increased incidence of dislocation is because when the hip 
is in a functional position of hip flexion and internal rotation, there is 
considerable tension on the posterior joint capsule of the hip. The femoral head 
then has a propensity to dislocate with inadequate repair of the posterior soft 
tissues 2, 118, 129. Kwon et al. performed a meta-analysis to determine the rate of 
dislocations using a posterior approach with and without posterior soft tissue 
repair and found an 8 times greater relative risk of dislocation when soft tissue 
repair was not performed 118. This finding is supported by a recent study by Ho 
and colleagues, who also determined that larger femoral head diameter also 
reduces the risk of hip dislocation in THA with a posterior approach 132. This is 
because larger femoral heads have an increased jump distance, or the distance 
the component must travel before it dislocates over the rim of the acetabulum 
27
. Using a larger femoral head diameter is a commonly cited preventative 
measure in patients at risk of dislocation following THA 134-136. 
 
The sciatic nerve is a structure at risk of injury during the posterior approach. It 
can be damaged during soft tissue dissection, traction on the extremity, or 
during repair of soft tissues during closure 2, 137, 138. A classic study by 
Schmalzried et al. reviewed over 3000 THAs and found an isolated sciatic 
nerve palsy incidence of 1.3% 139. In most cases, sensory or motor deficits 
resolve spontaneously. However, preserving the integrity of the nerve in order 
to optimize patient outcomes following THA cannot be understated 138.
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Chapter 2 
 
2 Literature Review 
Chapter 1 introduced hip arthritis, the myriad of treatments available to treat the 
condition, and an overview of total hip arthroplasty (THA). It also discussed the 
three main surgical approaches used to perform a THA. The purpose of this 
literature review is to compare clinical performance in patients having a hip 
replacement through an anterior, posterior, or lateral approach. A discussion of 
economic analyses in the field of medicine and the economic impact of THA on 
health care systems will ensue. Finally, the impact of surgical approach on 
health economics and the paucity of literature in the setting of THA will be 
reviewed.  
 
2.1   Comparing surgical approaches in total hip 
 arthroplasty 
 
There is a great debate in orthopedic surgery as to which surgical approach to 
the hip will produce the best clinical outcomes following a THA. Several studies 
have compared the different approaches using various methodologies. 
Currently, proponents of muscle-sparing approaches such as the anterior 
approach claim that using this approach will reduce post-operative pain, lower 
peri-operative blood loss, restore function sooner, and reduce length of stay in 
hospital 1. This section will outline the literature to support or dispel these claims 
following a brief overview of the different outcome measures used to compare 
the approaches. 
 
2.1.1 Clinical outcome questionnaires 
There are a multitude of outcome questionnaires available to assess pain, 
mobility, level of functioning, and radiographic features associated with hip 
arthritis 2, 3. These questionnaires are often scoring systems that allow 
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physicians to objectively track patients’ responses to surgical intervention such 
as THA 4. The Harris Hip Score (HHS), Western Ontario and McMaster 
University Osteoarthritis Index (WOMAC), Short-Form 12 (SF-12), and EQ-5D 
questionnaires are common examples 5-8. Ideally, these questionnaires assess 
disease-specific and overall aspects of the patient’s health with proven validity, 
reliability, and responsiveness to clinical change (Figure 2.1) 3, 9, 10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1 – Traits of an ideal clinical questionnaire 
 
Reliability, validity, responsiveness, and the ability to administer a questionnaire 
in a timely manner with minimal costs are all considered when choosing a 
questionnaire for research purposes (S Petis). 
Ideal clinical 
questionnaire 
Reliable Feasible administration 
Proven validity 
Responsive to clinical 
change 
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2.1.1.1 Assessing clinical outcome questionnaires 
There are several different characteristics used to describe outcome measures 
and assess their utility in determining patient outcomes. Questionnaires may be 
disease-specific, where the questionnaire explores specific complaints about a 
particular disease process, or generic, which are applicable to any intervention 
or disease and capture information about physical, social, emotional, and 
mental functioning. Disease processes such as hip arthritis can impact the 
elements assessed in generic scales, thus disease-specific and generic 
questionnaires are often employed together to determine a patient’s response 
to an intervention 9, 11. 
 
Validity is a crucial criterion of a useful outcome questionnaire. Valid 
questionnaires are those that measure what they intended to measure 9. The 
COSMIN initiative (COnsensus-based Standards for the selection of health 
Measurement INstruments) concisely outlines the various domains within 
validity 10. Content validity assesses the relevance of each item in a 
questionnaire and how well it addresses the constructs, or abstract variables of 
a questionnaire. Also important is criterion validity, which correlates the 
outcome score with a supposed “gold standard” assessment tool for a given 
condition 12. An invalidated questionnaire will not be useful in determining 
patient’s responses to an intervention in a specific patient population 3. 
 
An applicable outcome questionnaire in clinical research should also be 
reliable. Reliability reflects a scale’s ability to reproduce similar results when 
administered on more than one occasion 9. There are several dimensions to 
reliability. Internal consistency refers to the redundancy of items in a 
questionnaire when assessing different constructs. Inter-rater reliability refers to 
achieving similar results on a questionnaire when administered by different 
people. Intra-rater reliability refers to getting similar results when either the 
same person is administering the test over and over, or is being completed by 
the same person on a different occasion. Test-retest reliability measures how 
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stable outcomes are on a given questionnaire when tests are repeated after a 
short amount of time has elapsed 13. Reliability is subject to measurement error, 
which can influence the true variability between patients completing an outcome 
questionnaire 14. Using the standard error of measurement (SEM), the smallest 
detectable change (SDC) can be calculated. The SDC refers to a real change in 
the score not due to error in response to an intervention 15. 
 
Another important consideration when choosing a questionnaire is how well it 
will detect important changes following some intervention, a term called 
responsiveness 11. Generally, disease-specific scales are more responsive than 
generic scales 16-19. This also relates to the minimal important difference (MID), 
which is the smallest difference in scores on an outcome questionnaire that the 
patient would perceive as important 20. The MID can influence a clinician’s 
decision to embrace or abandon a particular intervention 9. Generally, the SDC 
should be less than the MID for this to be the case 15. 
 
Finally, floor or ceiling effects are also considerations when choosing a 
questionnaire to measure health-related changes to an intervention. These 
phenomena occur if greater than 15% of respondents to a questionnaire attain 
the lowest (floor) or highest (ceiling) score. This suggests that the questionnaire 
may be missing items that assess the absolute best or worst possible clinical 
scenario or state of health 15. All of the aforementioned qualities of a health-
related outcome questionnaire should be considered when choosing which 
ones to include as part of a clinical research trial.  
 
2.1.1.2 Harris hip score 
The HHS was developed in the 1960s and was designed to assess pain and 
function in those individuals living with hip pathology, and to objectively 
ascertain their response to treatment 5. It is a score out of 100, with pain (44 
points) and function (47 points) receiving the highest contribution to the overall 
score. A high score represents a positive outcome. The functional scores 
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assess daily activities, as well as the individual’s gait. The remaining points are 
culminated by range of motion and the presence or absence of a fixed hip 
deformity. It was originally tested and validated in 39 patients undergoing hip 
arthroplasty for post-traumatic arthritis 21.  
 
The HHS is an example of a disease-specific outcome measure. The 
questionnaire must be completed by a health professional as it includes 
objective assessments such as range of motion, deformity, and gait 3. Since its 
inception in the 1960s, it is one of the most widely utilized outcome 
questionnaires in patients undergoing THA. Soderman and Malchau 
demonstrated that the HHS was a valid and reliable measure in a cohort of 344 
patients who underwent THA 22. Shi and colleagues showed that the HHS was 
more responsive to post-operative changes in pain and function following a 
THA than a generic questionnaire, particularly within the first year 23. However, 
it should be noted that the HHS does not account for patient characteristics that 
may impact some of the scores (i.e. a patient with severe cardiorespiratory 
disease and their walking tolerance) 3. As well, a systematic review suggests 
that the HHS may succumb to ceiling effects in younger patient populations 
undergoing THA such as those with a primary diagnosis of acetabular or 
femoral dysplasia 24. 
 
2.1.1.3 Western Ontario and McMaster University Osteoarthritis 
  Index 
 
The WOMAC is another example of a disease-specific questionnaire. 
Developed in the 1980s, the questionnaire is completed by the patient and 
includes 24 questions to assess pain, stiffness, and physical function 
associated with hip arthritis 6. Each question is assigned 0 to 4 points 
depending on the patient’s response, and is then normalized to a score out of 
100 3. Again, a higher score is a positive outcome. In the literature, it is a 
validated and reliable measure of assessing the response to intervention in 
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patients with hip arthritis 6, 25-27. A change score following an intervention of 9-12 
points on the WOMAC is considered a MID 25.  
 
2.1.1.4 Short-Form 12 
The SF-12 questionnaire was derived from the Medical Outcomes Study 36-
item Short-Form Health Survey (SF-36) 28. The SF-36 is a validated and reliable 
generic health outcome questionnaire that assesses both physical and mental 
aspects of health through a Physical Component Summary (PCS) and Mental 
Component Summary (MCS) score, respectively 29. The PCS and MCS are 
further broken down into 4 domains each. The goal of designing the SF-12 was 
to produce a self-administered health survey that was reliable, valid, could be 
published on a single page, and took less time to complete than the SF-36 28. 
 
The derivation of the SF-12 healthy survey occurred in the mid-1990s.  Ware Jr. 
et al. chose 12 items from the SF-36 health survey to represent the PCS and 
MCS scores in the SF-12 survey. They found that the items selected were 
reliable predictors of the SF-36 scores in a United States population 28. The 
survey has now been validated in several other countries around the world 30. A 
change score of 3-5 points on the SF-12 is considered a MID 31. It has become 
an important measure of health-related quality of life in joint replacement trials, 
as both the PCS and MCS scores are impacted substantially by hip arthritis 32, 
33
. 
 
2.1.1.5 EQ-5D 
The EQ-5D is another example of a generic health outcome questionnaire. 
Devised by the EuroQol Group in the 1980s, the EQ-5D consists of 5 questions 
and a visual analogue scale to assess health related quality of life. The 5 
questions assess mobility, self-care, usual activities, pain, and 
anxiety/depression using three degrees of severity (no problems, some 
problems, severe problems). Each response is assigned a level from 1 to 3 for 
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each question (level 1 = no problems, level 2 = some problems, level 3 = severe 
problems), creating a unique 5-digit health state. Therefore, there are 243 
possible health states generated by using this questionnaire 8.  
 
Once the 5-digit state has been determined, a summary index can be 
calculated. Each level is assigned a weighted value that has been determined 
from valuation studies in a given population 8. This valuation is based on utility 
theory, where members of a population will have preferences regarding 
particular states of health. These preferences were weighted using a time-
tradeoff method. During valuation of the ED-5D, community respondents were 
asked whether they would spend more time in a less desirable state of health 
followed by death, or less time in a more desirable state of health followed by 
death. The 5-digit state can then be used to calculate the summary index 
between -1 and 1, where 1 is perfect health, 0 is death, and any negative value 
is a state considered worse than death 13. This index is useful in that it can be 
used to calculate Quality Adjusted Life Years (QALYs) in economic 
evaluations3.  
 
The EQ-5D has proven to be a valid and reliable measure in assessing quality 
of life adjustment following THA 34, 35. A MID of 0.074 has been reported for the 
EQ-5D questionnaire 36. A valuation study has been completed in Canada, 
providing useful information for determining summary indices in Canadian study 
populations 37. 
 
2.1.2 The lateral versus posterior approach 
The lateral and posterior approaches are fundamentally similar in that they are 
both muscle-splitting approaches to the hip 38. However, as illustrated earlier, 
the surrounding anatomy and potential complications for each approach are 
much different. Therefore, it is worthwhile to review the literature to determine 
whether these differences influence patient outcomes. 
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A common discriminative endpoint used to determine the clinical effectiveness 
between the lateral and posterior approach is dislocation rate. Intuitively, 
patients are more satisfied with surgery and experience better quality of life if 
they do not experience a post-operative dislocation 39, 40. After compiling studies 
that examined dislocation rate and surgical approach, a systematic review by 
Masonis and Bourne demonstrated a dislocation rate of 3.23% and 0.55% for 
the posterior and lateral approaches, respectively 41. A review of over 78,000 
THAs performed in Sweden suggested a slightly higher dislocation rate when 
hip replacements were performed through a posterior approach 42. Conversely, 
a Cochrane Review in 2006 identified no difference in dislocation rate between 
the two approaches 43. Another comprehensive review by Kwon et al. showed 
that with a careful soft tissue repair of the posterior joint capsule, the posterior 
approach has a similar dislocation rate to the lateral approach (0.49% vs. 
0.43%) 44. The literature suggests that with careful soft tissue closure and 
utilization of larger diameter femoral heads, the dislocation rate is similar 
between the two approaches 45-47. 
 
Another common comparator between the posterior and lateral approach is the 
incidence of abductor insufficiency. Several studies have suggested the lateral 
approach has an increased incidence of abductor insufficiency following THA 41, 
43, 48, 49
. However, there is tremendous heterogeneity in the methods used to 
diagnosis abductor insufficiency in many of these studies. Many studies use 
subjective findings to make the diagnosis, such as the presence of 
Trendelenburg gait or sign or lateral trochanteric pain, which may suffer from 
poor inter-rater reliability. Magnetic resonance imaging (MRI) is becoming a 
popular modality for assessing soft tissue pathology following THA 50-53. Several 
studies have shown that metal suppression pulsed MRI sequences can identify 
abductor damage in patients with symptomatic abductor tears following THA 52-
54
. Future prospective studies using MRI to assess soft tissue integrity post-
operatively will provide a more objective measure of the incidence of abductor 
tears and clinical insufficiency. 
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The most important determinants of a successful THA are based on its 
indications: pain mitigation, improved quality of life, and restoration of function 1. 
These measures are inferred by the use of the aforementioned questionnaires 
in clinical trials. An early study by Barber et al. prospectively followed 28 
posterior and 21 lateral THAs for 2-years, each performed by a single surgeon. 
It should be noted the posterior joint capsule and short external rotators were 
not repaired in the THAs performed through the posterior approach. Both 
groups had similar improvements on the HHS at 2-year follow-up and had no 
observable differences in dislocations or the incidence of a Trendelenburg gait. 
The authors suggest that with meticulous surgical dissection, both the lateral 
and posterior approaches produce a THA with excellent patient outcomes and 
minimal sequelae at intermediate follow-up 55. 
  
A more recent prospective study randomly assigned 60 patients to undergo a 
THA through either a posterior or lateral approach. Their primary end-point was 
the HHS at 12-week follow-up. They also captured data from the WOMAC and 
SF-36 questionnaires, as well as complications such as dislocations and peri-
prosthetic fractures. Both approaches showed similar improvements across the 
HHS, WOMAC, and SF-36 questionnaires at multiple time points up to and 
including 12-weeks post-operatively. The rate of dislocation and fracture did not 
differ significantly between the groups 48.  
 
There are surprisingly few clinical trials directly comparing clinical outcomes 
following THA using either of these two approaches 43. The current study will 
compare these two approaches and add valuable patient reported outcome 
data to the literature. 
 
2.1.3 The anterior versus lateral approach 
The anterior approach is the preferred surgical approach of 10% of orthopedic 
surgeons performing THA 56. Reduced blood loss, earlier functional recovery, 
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low dislocation rates, and shorter stays in hospital have been attributed to the 
muscle-sparing properties of the anterior approach 57. Current literature also 
suggests that minimizing muscle damage during surgery is a reason for patients 
to choose particular surgeons performing muscle-sparing techniques 58. Thus, 
several recent studies have compared the anterior approach to both the lateral 
and posterior approaches. 
 
From 2006 to 2009, Alecci et al. retrospectively reviewed peri- and intra-
operative outcomes of THAs performed through either a lateral (n=198) or 
anterior (n=221) approach. Mean operative time was 8 minutes longer in the 
anterior group, which was a statistically significant difference between the 
groups. The lateral group observed increased peri-operative blood loss and 
increased number of blood transfusions compared to the anterior group. 
However, the pre-operative hemoglobin was lower in the lateral group, and they 
received significantly more fluid throughout each procedure, which may have 
contributed to hemo-dilution. Finally, length of stay in hospital was reduced 
significantly from 10 to 7 days when a THA was performed through an anterior 
approach 59.  
 
A similar study by Restrepo et al. randomly assigned 100 patients to either the 
anterior or lateral approach before undergoing a THA. Interestingly, they found 
no significant differences in operative time, blood loss, need for blood 
transfusions, and length of stay in hospital between the two groups. The 
authors also examined patient outcome measures. The anterior group 
outperformed the lateral group for the HHS, SF-36, and WOMAC 
questionnaires at 6-weeks post-operatively. However, these significant 
differences in clinical outcomes abated when revisited at 2-years post-
operatively 60. This study suggests that the anterior approach may promote 
earlier patient satisfaction and restoration of function compared to a lateral 
approach cohort.  
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Earlier discharge from hospital using an anterior approach may be due to better 
pain mitigation following surgery. Goebel et al. retrospectively reviewed pain 
perception using a visual analogue scale (VAS), consumption of pain 
medication, and length of stay in hospital in 200 patients having either an 
anterior or lateral approach for THA. There was a significant reduction in 
perceived pain and consumption of pain medication in the anterior group during 
the first 24 hours post-operatively. The anterior group spent approximately 3 
days less in hospital as well. Again, improved pain mitigation and earlier 
discharge were attributed to the muscle-sparing properties of the anterior 
approach 61. However, the accuracy of this data is limited by the retrospective 
study design, as well as pain assessment using a VAS and multiple assessors. 
 
There may be an anatomic aberrancy that can explain the discrepancy in 
perceived pain between the groups. Bremer et al. performed a MRI 1-year post-
operatively in 50 patients having a THA through either an anterior or lateral 
approach. They noted significant increases in the number of abductor tears or 
detachments, greater trochanteric fluid collections, gluteus medius tendinosis, 
and fatty atrophy of the abductor muscles in the lateral group 62. The abductor 
complex is a pain generator following the lateral approach and may explain 
differences in early pain perception between the groups 63. However, a 
limitation of this study includes the absence of clinical outcome measures 
assessment. A pre-operative MRI was not performed, which could have 
identified patients with evidence of abductor pathology prior to THA, a common 
finding in patients with hip arthritis 64. Future research should compare clinical 
outcomes and findings on advanced imaging modalities to explain 
discrepancies in pain and functional outcomes. 
 
2.1.4 The anterior versus posterior approach 
Several studies have also compared the anterior and posterior approaches 
using various outcomes. Length of stay in hospital, operative time, and clinical 
questionnaire scores such as the HHS are some examples of comparative 
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outcomes. Recent literature has also examined the degree of muscle damage 
bestowed by each approach. 
  
A prospective randomized trial by Barrett et al. compared 43 anterior and 44 
posterior approaches to THA. The primary end-point was the ability to climb 
stairs and walk unlimited distances as assessed on the HHS at 6-weeks, 3-
months, 6-months, and 12-months post-operatively. The authors also captured 
intra-operative data including total operative time, and post-operative data such 
as length of stay in hospital. Total operative time was 23.8 minutes longer in the 
anterior group (p<0.05). Length of stay in hospital was 2.28 days for the anterior 
group and 3.02 days for the posterior group (p<0.05). At the 6-week follow-up 
visit, significantly more patients were walking limitlessly, were able to climb 
stairs normally, and had a higher total HHS in the anterior group. These 
differences dissipated by the 3-month mark and remained insignificant up to 
and including 1-year post-operatively 65. This study supports the claim that the 
anterior approach provides earlier restoration of function following THA. 
 
Again, one of the purported benefits of the earlier functional return is earlier 
discharge from hospital. Martin et al. retrospectively reviewed 41 anterior and 
47 posterior approaches for THA. Hospital length of stay was significantly 
shorter for the anterior group (2.9 versus 4.0 days). Mean operative time was 
significantly longer in the anterior approach cohort (141 versus 114 minutes). 
Both groups performed similarly on the SF-36 and WOMAC clinical outcome 
measures at 6-month follow-up. This study did suffer from selection bias, as the 
mean body mass index (BMI = kg/m2) was significantly higher for the posterior 
approach group (34.1 versus 28.5 kg/m2). The authors stated that many 
patients with obesity declined having an anterior approach when the surgeons 
conveyed that the procedure was more technically demanding in patients with a 
higher BMI. Anecdotally, patients with obesity do require more assistance with 
early mobilization, which may have explained the difference in length of stay 
between the groups 66. 
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There is considerable interest in the amount of muscle damage sustained 
during surgical approaches to the hip. An interesting study by Bergin et al. 
compared various blood markers indicative of muscle damage in patients 
undergoing a THA through either an anterior or posterior approach. This 
methodology has been used previously to justify the use of tissue-sparing 
techniques such as laparoscopy in other surgical subspecialties 67, 68. The 
investigators measured pre- and post-operative values of various acute phase 
reactant proteins such as creatine kinase (CK), C-reactive protein, interleukin-6, 
tumor necrosis factor-alpha, and interleukin-1 in 57 patients undergoing THA. 
They found a significant rise in CK in the posterior approach group compared to 
the anterior approach group immediately following the procedure, as well as 
cumulatively after two days following THA. The other acute phase reactants did 
not change significantly between the groups 69. However, the operative time in 
the posterior approach cohort was longer, with a mean of 118 minutes versus 
78 minutes for the anterior group. A more prolonged period of immobilization on 
the operating room table could have contributed to accumulation of additional 
serum CK 70. Serum CK clearance is also dependent on renal function, which 
was not accounted for in this study 71. 
 
Another study examined the extent of gluteus medius/minimus, tensor fascia 
latae, rectus femoris, and short external rotator muscle damage in THAs 
performed on 12 cadaveric hips (6 anterior and 6 posterior approaches). Three 
different evaluators assessed the surface area of muscle damage from fixed 
bony landmarks. Minimal damage was sustained to the gluteus medius muscle 
through both approaches. The posterior approach caused more damage to the 
gluteus minimus muscle than the anterior approach (18% versus 8.5% of the 
mean surface area). The short external rotators were released in all posterior 
approach specimens and were damaged in 50% of the anterior approach 
specimens in order to improve visualization of the proximal femur. Using an 
anterior approach, 31% and 12% of the mean surface area of the tensor fascia 
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latae and rectus femoris muscles, respectively, was damaged. No damage to 
either of these muscles was sustained using a posterior approach 72. This study 
is limited by its use of cadaveric specimens, which would respond differently to 
physiologic loads during surgery in-vivo. As well, muscles are 3-dimensional 
structures, thus volume would have been a more accurate parameter of 
assessing muscle damage. This study challenges the claim that the anterior 
approach is truly a muscle-sparing approach. Future studies using gait analysis 
could elicit the clinical effects of this muscle damage.  
 
This review has demonstrated that all three surgical approaches allow surgeons 
to perform a clinically effective THA procedure. The next step is to evaluate the 
cost of surgical interventions such as THA. It is important that surgical 
procedures be rigorously reviewed to determine whether the cost of treating 
each patient results in a justifiable accentuation of patient function and quality of 
life. 
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2.2 Health economics and total hip arthroplasty 
Despite its technical and tribological intricacies, THA is often heralded as one of 
the most successful surgical interventions in medicine 4. In 2005, approximately 
21.4 million Americans were living with osteoarthritis. In 2030, that number is 
expected to rise to 41 million, largely attributable to improved management of 
chronic diseases and prolonged life 73. Thus, the burden of hip arthritis may 
overwhelm the available resources within healthcare systems. 
  
Therefore, it is important for physicians, patients, hospital administrators, and 
society at large to understand the costs of these procedures. Implants and 
surgical approaches used for THA are subject to new innovation, potentially 
resulting in increasing costs 74. There are pressures to produce the best clinical 
outcome, while remaining cognizant of the costs associated with any 
intervention 13. Total hip arthroplasty has been subjected to numerous cost 
analyses 75-80. However, none of these analyses suggest whether surgical 
approach has a significant impact on health care costs. The purpose of this 
section is to provide a concise overview of cost-analysis and its use in THA.  
 
2.2.1 Types of cost analyses in medicine 
A variety of methods exist to evaluate the costs associated with medical 
interventions. These include cost-minimization/identification analysis, cost-
consequence analysis, cost-benefit analysis, and cost-effectiveness analysis.  
  
2.2.1.1 Cost-minimization analysis 
Cost-minimization analysis is a type of cost-analysis. These analyses are useful 
when decisions are solely based on costs because the effectiveness between a 
new or experimental treatment is presumed to be equal to the comparator 13. 
Therefore, cost-minimization analysis seeks to identify the cheapest means of 
attaining similar health outcomes across a treatment and its alternative 81.  
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2.2.1.2 Cost-consequence analysis 
Cost-consequence analysis disseminates all costs and all outcomes associated 
with interventions and do not combine these parameters into a ratio 82. Cost-
consequence analysis expects a consumer to make value judgments on a list of 
costs and outcomes associated with an intervention and an alternative. Simply 
stated, the interpreter of the analysis creates their own list of pros and cons in 
order to choose the intervention that best suits their needs 13. One advantage of 
this type of analysis is how the information can be presented to its users. The 
results of the study are often presented in a table format rather than ratios 
commonly cited in cost-analysis, which may increase the accessibility of the 
information 82.  
 
2.2.1.3 Cost-benefit analysis 
A cost-benefit analysis involves expressing both the costs and health outcomes 
associated with an intervention in dollars. The outcome measures are assigned 
a dollar value by using a willingness to pay value, which is usually inferred from 
surveys. This is one of the disadvantages of using a cost-benefit approach, as 
people often find it difficult to assign dollar values to intangibles such as health. 
If the health benefits valued in dollars less the cost of the intervention is 
positive, than that intervention is considered worthwhile. The cost information 
required to perform a cost-effectiveness analysis can also be used for cost-
benefit analyses 13. 
 
2.2.1.4 Cost-effectiveness analysis 
At its roots, cost-effectiveness analysis relates the costs accrued during an 
intervention to health outcomes in the form an incremental cost-effectiveness 
ratio (ICER). This ratio can be generated and compared across various 
alternative forms of treatment to determine the lowest cost to achieve a desired 
  71 
health outcome. The ICER can also be used to compare interventions across 
different disease states to help payers determine which interventions are the 
least costly, yet achieve a desired health outcome (i.e. costs of statin therapy 
versus total hip arthroplasty in attaining QALYs) 13. Incremental cost-
effectiveness is different than marginal cost-effectiveness. Marginal cost-
effectiveness disseminates the costs within a single intervention, such as the 
cost of adding or removing a day in hospital 83. Several considerations need to 
be taken when designing any cost-analysis study. 
 
2.2.1.5 Importance of perspective 
When designing a study examining costs, it is imperative to understand how the 
target audience will use the information to facilitate decision-making regarding a 
particular intervention. The literature suggests that a societal perspective should 
be used when conducting a cost-analysis study in order to influence resource 
allocation 84. This perspective ensures that any event that may affect a patient’s 
health is included as either a cost or effect 84. The societal perspective ensures 
that the cost-analysis captures many events that are apart of routine care, such 
as rehabilitation, educational programs, and other patient expenses. Other 
common perspectives include those of hospitals or clinics, insurance 
companies, and patients 13. 
 
2.2.1.6 Setting boundaries 
A term closely associated with perspective is the boundary imparted by the 
cost-analysis. Boundaries simply refer to the scope of patients and health 
outcomes that will be included, or excluded, in the analysis. In order for the 
analysis to exemplify society, a well-designed cost-analysis often has few 
exclusion criteria. Developing a cost-analysis with few exclusion criteria will 
capture various people living with the disease, living within the spectrum of that 
disease, and the individuals impacted by caring for an afflicted individual. The 
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health outcome can be non-specific, such as life-years gained, or focus on 
constituents of health, such as physical pain, mental status, or functionality 13. 
 
2.2.1.7 Determining the costs 
There are a multitude of costs that should be compiled during a cost-analysis. 
Ideally, the data on cost is accumulated in a prospective study; however, many 
studies retrospectively retrieve data from databases. It is not uncommon for 
investigators to add a cost-analysis to an ongoing randomized-controlled trial 
(RCT), which is referred to as piggybacking. Although piggybacking may 
conduct a cost-analysis in a time efficient manner, the RCT protocol may 
impose additional costs to hospitals and patients that may not be representative 
of routine care. Additionally, these studies are often powered to demonstrate 
significance in clinical outcomes rather than cost-effectiveness. Finally, these 
piggyback studies may lack external validity as the patients selected for the 
study may not represent the general population, and they are being treated 
under restrictive circumstances. Thus, a more meaningful design includes cost-
effectiveness as the primary outcome, thereby depicting routine clinical practice 
in costs and outcomes 13. 
 
There are two methods of capturing costs included in a cost-analysis. One 
method is gross-costing, where estimates are used to derive a final cost. This is 
in contrast to micro-costing, which attempts to attach an exact cost to each 
resource consumed by each patient during an intervention. Immediacy of cost 
calculations is the major advantage of using a gross-costing method. Micro-
costing is much more labour-intense, but if done well, would provide a gross-
costing estimate for future studies. Although costs used for both methods can 
be acquired retrospectively, the analyst must consider the generalizability of the 
data used and whether it satisfies the chosen perspective 13. 
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2.2.1.7.1 Direct costs 
Direct costs refer to the dollar amounts required to run an intervention or 
treatment algorithm in a cost-analysis 83. These costs can be subdivided into 
direct medical/health care costs and direct nonmedical/non-health care costs. 
Direct medical/health care costs include expenditures such as inpatient 
hospitalization, medications, radiographs, laboratory investigations, or implants 
for a THA. Direct nonmedical/non-health care costs are other expenditures 
required for completion of an intervention, such as patient transportation, care 
on behalf of family members, gait aids, or home modifications. These direct 
costs are contained in the numerator of a cost-effectiveness ratio 13, 83. 
 
When considering the societal perspective for a cost-analysis, it is sometimes 
difficult to account for direct costs such as time spent waiting for treatment or 
unpaid caretaking on behalf of family members (also known as home 
production). In general, most cost-analyses apply the average wage of a person 
of similar gender and age to those opportunity costs. In this way, the external 
validity of the costs contained in the numerator will be optimized 13.  
 
2.2.1.7.2 Indirect/productivity costs 
Indirect/productivity costs are other cost considerations for cost-analysis. The 
morbidity caused by an intervention may result in lost time to work, or the 
inability to partake in leisure activity. There is also lost productivity due to 
mortality associated with particular interventions or disease states 83. The time 
lost to work or leisure activity during recovery from an intervention such as 
surgery would undoubtedly have financial implications for the patient, as well as 
impacting their health-related quality of life. In cost-analysis, these productivity 
costs are included in the denominator of a cost-effectiveness ratio and are 
reflected in health outcomes such as QALYs. Productivity costs can be 
monetized for the purposes of cost-benefit analysis when necessary 13. 
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2.2.1.8 Methods of assessing effectiveness 
As mentioned earlier, cost-utility analysis is a type of cost-analysis. It is based 
on utility theory, which states that individuals place preference-weights on 
particular states of health 83. Several questionnaires have been developed to 
capture a utility index, with values ranging from 1 (perfect health) to 0 (death), 
and any negative value representing states of health perceived to be worse 
than death 8, 13, 85-87. As discussed in the section on the EQ-5D, this utility index 
allows the analyst to calculate QALYs 13. 
 
Health-related quality of life determines each utility index. Several dimensions 
encompass health-related quality of life, such as physical function, 
psychological function, sensory impairment, social function, and pain. Again, 
questionnaires that allow derivation of a utility index are based on population 
studies where individuals have been asked to place preference weights on 
certain health states. The preference weights used in these questionnaires are 
typically derived from two methods: standard gamble or time-tradeoff 
(discussed earlier under EQ-5D) 13.  
 
The standard gamble method literally asks respondents to gamble with various 
states of health. First, they are asked whether they would want to live 
indefinitely with an assigned state of health. If not, the individual can choose to 
gamble on achieving a full state of health or death. The probabilities of 
achieving the various health states are altered until the individual feels there is 
no difference between accepting the assigned state of health or gambling 88. 
Many behavioural scientists contest that the general population may have 
difficulty gambling on states of health, thus limiting the utility of this approach 13.  
 
Quality-adjusted life years are then calculated by multiplying the utility index by 
the length of time spent in that health state. The benefits of using QALYs are 
that they not only capture improvements in health-related quality of life while 
two cohorts are alive, but they also determine health-related quality of life from 
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prolonged life if there is a mortality benefit from undergoing a particular 
intervention 13. 
 
2.2.1.9 Time horizons 
Cost-analysis involves time horizons. A time horizon refers to an interval of time 
required to observe potential health-related and economic implications of an 
intervention. In medicine, most investigators are interested in the lifelong effects 
of a treatment or procedure. Therefore, most prospective studies are not 
capable of capturing health and economic data with a time horizon equivalent to 
the length of a human life 13. 
 
In order to accommodate for this, many studies use models to extrapolate cost 
and health effects of an intervention until a person’s death. Many cost-analyses 
will report prospectively collected cost data using a short time horizon that 
includes the follow-up outlined in the study, and model a second set of data to 
include the longer time horizon 13. 
 
2.2.2 Cost-analysis in total hip arthroplasty 
Total hip arthroplasty has been subjected to cost-analysis, with the earliest 
studies dating back to the 1990s 75, 77. Although THA is an effective treatment 
modality for debilitating hip arthritis, it is an expensive procedure performed 
more frequently each year 73, 89-92. For example, the Canadian Institute for 
Health Information reported that the number of hip and knee replacements 
performed in Canada increased from 82,700 in 2007 to 93,450 in 2011. In the 
United States, some authors suggest that upwards of 500,000 THAs will be 
performed annually by 2030 73. These figures will undoubtedly place a 
tremendous burden on financial resources available for health-care 
administration. Therefore, it is important to understand the burden of hip 
osteoarthritis, and the cost associated with common procedures such as THA. 
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2.2.2.1 Economic burden of hip arthritis 
Several studies have tried to capture the direct and indirect costs for patients 
living with arthritis. A Canadian study by Maetzel et al. determined that the 
costs incurred by patients living with osteoarthritis amounts to $5700 annually 
(1999 Canadian dollars). Sixty-nine percent of these costs are direct, such as 
hospitalization, drugs, and assistive devices, and 31% are indirect costs 93. In 
Canada, the overall financial burden of osteoarthritis was estimated to be 
between 4.3 and 7.3 billion dollars (1994 Canadian dollars) 93. A study in the 
United States by Leigh et al. quoted an annual cost of 89 billion dollars for all-
comers with osteoarthritis (1994 US dollars) 94. As life is prolonged through 
medical advancements, the number of individuals living with arthritis will rise 
and continue to incur tremendous health-care costs 73. 
 
There are few studies capturing the costs incurred by patients living with hip 
arthritis. One study by Gupta et al. used questionnaires to acquire direct and 
indirect costs over 2 years in 1200 Canadians living with arthritis of their hip or 
knee. The WOMAC questionnaire was used to assign disease severity to each 
participant. Their perspective was that of the patient, thus they excluded several 
direct costs including hospital admissions, prescription drugs, and 
physiotherapy. They determined an average cost of $12,200 annually (2002 
Canadian dollars), where approximately $10,000 of this total encompassed 
indirect costs (i.e. home-care programs, paid employment time lost, and costs 
of caregivers). Predictors of increasing costs were advanced age, more severe 
arthritis based on WOMAC performance, and lower socioeconomic status 95. 
Unfortunately, these costs were not reported separately for hip and knee 
arthritis. The cost information was also dependent on patient recall, thereby 
limiting the accuracy of the aggregated cost 96. 
 
Another study prospectively acquired direct medical costs of 70 Australians 
living with hip or knee arthritis. A customized cost questionnaire was distributed 
to study participants in 4 3-month intervals. The maximum annual direct medical 
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costs incurred to patients in this study was $2,700 (1994 Australian dollars). 
Predictors of increased expenditures included female sex, age over 65, poorer 
performance on both the WOMAC and SF-36 questionnaires, and living with 
arthritis for a prolonged period of time 97. Although this study captured many 
“out-of-pocket” costs that patients may encounter living with arthritis, it did not 
collect information on direct non-medical costs or indirect costs. 
    
A more recent study by Rolfson et al. examined the costs of 2635 Swedish 
individuals with hip arthritis on the surgical waiting list for THA. A cost 
questionnaire was distributed to each patient, which outlined working status (i.e. 
working, retired, sick leave, or disability support pension), living situation, 
medications, community support, modifications made to living arrangements 
(i.e. wheelchair accessibility), transportation costs, and care from other 
individuals. The participants were asked to report information for the 12 months 
prior to receiving the questionnaire. Estimates were used to approximate costs 
of community home care and home modifications. Age and gender-specific 
mean incomes were used to estimate productivity losses for those taking time 
away from paid employment, as well as costs incurred to those providing 
informal care. The investigators also examined time spent waiting for both 
orthopedic consultation and the day of surgery 98. 
 
The results of the study suggest an average annual cost of $7,666 for patients 
living with hip arthritis (2009 US dollars). Sixty-seven percent of the study 
population was retired at the time the questionnaire was distributed. Of those 
individuals not working, approximately 60% were on some form of sick leave or 
disability. Five percent of the cohort reported some form of home care, while 
43% of respondents had some form of home modification because of hip 
arthritis. Almost one-quarter of the study population required informal 
assistance from another caregiver. The mean wait time for orthopedic 
consultation was 176 days, while the mean time to surgery following 
consultation was 144 days. The majority of the reported costs (61%) were due 
  78 
to productivity losses (indirect costs) 98. This study provides useful information 
on many of the indirect costs incurred by patients living with hip arthritis in a 
publically funded health care system similar to Canada. Although the 
denominator of a cost-effectiveness ratio reflects productivity losses, this study 
illustrates the financial burden of hip arthritis for both patients and society 13. 
 
2.2.2.2 Cost of total hip arthroplasty 
Few studies have provided accurate estimations of the cost of THA. A multi-
center study performed in Canada and the United States determined the mean 
direct costs of a THA to be $6,766 and $13,339, respectively (2001 US dollars). 
Interestingly, this difference was evident despite a significant difference in the 
mean length of stay between the two countries: 4.2 days for the United States 
centers and 7.2 days for the Canadian centers. There was also a marked 
difference in the cost of implants between the two nations, with medians costs 
of $8,017 and $1,695 for the United States and Canada, respectively (2001 US 
dollars). The cost of the implants, along with differences in overhead costs 
(administration, house-keeping, etc.), explained the cost disparity between the 
two countries 91. This study provides useful information from a payer’s 
perspective on how different health care budgeting frameworks can impact 
overall costs. However, it does not account for several other direct medical and 
non-medical costs associated with THA in the post-operative period. 
 
Another study examined costs associated with undergoing either a hip or knee 
replacement in Canada. Hospital costs associated with the index procedure and 
post-operative direct medical and non-medical costs were aggregated up to 6-
months following THA. The analysts determined a cost of $14,761 over the 6-
month period (2007 Canadian dollars). Costs were not disseminated for hip and 
knee replacements separately. Also, it was unclear how they determined 
relevant outpatient rehabilitative costs 99. 
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2.2.2.3 Is total hip arthroplasty cost-effective? 
It is clear from the discussion that THA is an expensive procedure to both the 
patient and the purveyor of health care resources. In Canada, with the number 
of THA procedures approaching 50,000 per year, millions of dollars will be 
spent to treat debilitating hip arthritis 90. However, the pain mitigation and 
restoration of function attained following this procedure is almost incomparable 
1, 4
. Although cost-analyses are sparse in the realm of THA, those that have 
been reported suggest it may be the most cost-effective procedure in all of 
medicine 1, 77. 
 
The study composed by Chang and colleagues is considered the benchmark in 
cost-analysis and THA. Their goal was to determine the cost-effectiveness of 
THA versus no treatment for osteoarthritis of the hip. The analysts used a 
model to determine long-term costs and functional outcomes in these two 
cohorts. A stochastic tree was used to model transition rates between health 
states, such as undergoing a THA and then dying peri-operatively, and the risk 
of other related health events, such as peri-prosthetic infection, aseptic 
loosening, peri-prosthetic fracture, or death from unrelated causes. This analytic 
technique was also used to model non-operative management, which includes 
either further functional deterioration or death from unrelated causes. 
Probabilities of peri-operative and natural mortality and revision rates were 
acquired from published literature. A societal perspective was taken to allow for 
comparison against other medical interventions 77. 
  
In order to measure effectiveness, they used the American College of 
Rheumatology (ACR) functional status classification. This classification ranges 
from I to IV, where class I would be the ability to complete all usual activities, 
and class IV is essentially being bed-ridden because of hip pain 100. Class III on 
the ACR classification was the prerequisite for needing a THA in their model 
(the ability of the patient to perform little to none of their usual activities). The 
authors used expert consensus to determine which ACR class corresponded 
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with Harris Hip and Mayo Hip scores in the literature. This allowed the authors 
to assign primary and revision THA procedures to a particular ACR class in 
their model. A standard gamble assessment was used to assign each ACR 
class a utility value to allow for the determination of QALYs 77. 
 
Costs were tabulated for both THA and those patients treated conservatively 
without surgery. Most of the costs used in the analysis were direct medical 
costs, including hospital admissions, time spent in the operating room, costs of 
the implants, physiotherapy, physician billings, and investigations. The cost 
data was largely derived from a hospital accounting system and averages from 
reported health care institutions such as nursing homes 77. 
 
With regards to their final analysis, the authors examined cost-effectiveness in 
men and women in 4 age categories: 60 years, 70 years, 80 years, and older 
than 85 year. At the extremes, THA was projected to be a cost-saving 
intervention in women aged 60 or younger. In men older than 85, the cost-
effectiveness ratio was $6100/QALY (1991 US dollars). Their model suggested 
that THA was still cost-effective even when revision rates were increased and 
peri-operative mortality increased 77. At that time, the only other comparable 
surgical intervention included coronary artery bypass graft for left main coronary 
artery disease, which had a reported cost-effectiveness ratio of $8100/QALY 
(1991 US dollars) 101. 
 
Cost-analyses are undoubtedly important tools in implementing innovative 
medical technologies given finite resources. Since 1996, cost-analysis has been 
used in the realm of THA to assess new bearing surfaces, fixation methods, 
and prosthetic implants 78-80. More recent cost-analysis studies have examined 
the cost-effectiveness of resurfacing hip arthroplasty versus conventional THA, 
and types of THA fixation 102, 103.  
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Surgical approach in THA is an area that warrants further investigation with 
regards to associated costs. This literature review outlines the differences in 
operating room time, length of stay in hospital, and time to functional recovery 
between the approaches. Each of these variables may have a significant impact 
on costs in THA, which is one of the rationales behind this thesis. 
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2.3 Rationale for thesis 
This literature review has outlined some of the comparative studies examining 
surgical approach in total hip arthoplasty. There is still a paucity of robust 
prospective studies comparing the three most common surgical approaches 
used in THA. Many of the comparative studies failed to use validated outcome 
measures to determine effectiveness. As well, the lack of inclusion of generic 
clinical questionnaires such as the SF-12 prohibits any discussion on the 
psychological effect of surgical approach in THA. The first study of this thesis 
will include a prospective comparison between the three surgical approaches 
using various validated outcome questionnaires. 
  
This chapter also reviewed the role cost-analysis has played in the arthroplasty 
literature. Surgical approach in THA has never been subjected to a cost-
analysis. The second study will examine the impact of surgical approach on 
costs following THA. This will include a comparison of various metrics such as 
operating room time, length of stay in hospital, and complication rates, metrics 
which surgeons find valuable when choosing a surgical approach for THA. 
  83 
2.4 Thesis objectives 
 This thesis has two primary objectives: 
1. To compare various clinical outcomes across three different 
surgical approaches used for THA. 
2. To determine the impact of surgical approach on costs following 
THA. 
 
2.5 Thesis hypotheses 
 The hypotheses based on these objectives are: 
1. There will be no difference on any of the validated outcome 
measures across surgical approaches at early follow-up. 
2. Surgical approach will have no significant impact on the costs 
associated with THA. 
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Chapter 3 
 
3 Surgical approach in total hip arthroplasty: The impact 
on short-term patient outcomes 
 
3.1 Introduction 
Sir John Charnley revolutionized the treatment of hip arthritis forever in the 
1960s. His low friction hip arthroplasty stood as the framework for the modern 
total hip arthroplasty (THA) 1. Although several tribologic advances have been 
made in implant design and bearing articulations, THA remains the most 
effective treatment modality for hip arthritis and is often regarded as one of the 
most important surgical advances in all of history 2.  
 
Basic science and clinical research remain integral components of improving 
the effectiveness of THA. Clinical trials allow clinicians to determine the impact 
of an intervention on a patient. These trials can also determine the indications 
and contra-indications for each intervention, factors that influence success and 
failure, and complications associated with a given procedure. Invaluable 
information is acquired from these studies when informing patients of the risks 
and benefits of any medical endeavor. 
 
There are several methods of assessing the effectiveness of any intervention. 
In the orthopedic literature, many clinical studies rely on validated, disease-
specific, and generic clinical questionnaires in order to document a patient’s 
response to an intervention. Other outcome measures include metrics such as 
operating room time, functional outcomes such as gait analyses, and 
complication rates. 
 
The impact of surgical approach on clinical outcomes in THA has been under 
scrutiny over the past decade. Prospective and retrospective studies have 
compared different surgical approaches in THA using a myriad of outcome 
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measures. Very few studies have used validated clinical outcomes in their 
comparisons, and to our knowledge none of the studies have standardized the 
implants used at the time of the index procedure. 
 
The primary objective of this study was to prospectively compare clinical 
outcomes across three different surgical approaches to the hip for THA, 
specifically the results on the Western Ontario and McMaster University 
Osteoarthritis Index (WOMAC). Using validated outcome measures, we look to 
elicit whether there is an early clinical benefit of performing a THA through an 
anterior approach. We will also compare complication rates between the 
approaches. We hypothesize that there will be no difference in clinical 
outcomes between the three different surgical approaches at short-term follow-
up. 
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3.2 Materials and Methods 
3.2.1 Study design, patient enrolment and selection 
Institutional review board ethics approval was attained at Western University. 
The study design was a prospective cohort observation study from a single 
institution. Patients were first assigned to the clinic of one of three fellowship-
trained arthroplasty surgeons at University Hospital at Western University. The 
surgeons were randomly assigned a day of the week to receive referrals from 
our central accepting database. Although not truly a randomized process, this is 
representative of usual clinical practice, thus strengthening the external validity 
of the study. Each surgeon performed only one of three surgical approaches to 
the hip: anterior (BL), posterior (JH), and lateral (EV). Informed consent for THA 
was attained for those patients whose hip arthropathy was deemed most 
appropriately treated with surgical intervention. 
 
One hundred and seventy eight consecutive patients were then approached for 
study enrolment in the preadmission clinic prior to their procedure from 
September 2013 to July 2014. Patients were included if they consented for THA 
performed through either an anterior, posterior, or lateral approach, were older 
than 19 years of age, and did not meet any of the exclusion criteria (Table 3.1). 
A letter of information was provided for each patient screened, followed by 
voluntary consent for study participation. 
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Exclusion Criteria 
Body Mass Index (BMI) > 40 kg/m2 
Legg-Calve-Perthes disease, slipped-capital femoral epiphysis, or developmental dysplasia of 
the hip (Crowe I or higher) 
Post-traumatic or inflammatory arthropathy 
Any previous hip surgery 
Simultaneous bilateral THAs 
Decision to change implants intra-operatively other than those approved for study 
Cemented THA 
Diagnoses that may preclude accurate completion of clinical questionnaires (i.e. Alcoholism, 
dementia, psychoses) 
Non-English speaking 
Inability to perform Timed Up-and-Go test (TUG) 
Cases performed by trainees (residents or clinical fellows) 
 
Table 3.1 – Study exclusion criteria 
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3.2.2 Patient demographics 
At the time of enrolment, patient age, sex, and BMI were collected. The primary 
diagnosis causing arthropathy of the hip joint (i.e. osteoarthritis, avascular 
necrosis) was determined based on patient history and radiographic images. 
Surgical approach and operative side were also recorded. 
 
3.2.3 Determining clinical outcomes 
Pre-operatively, each patient completed 4 different clinical questionnaires: 
Harris hip score (HHS), WOMAC, Short-Form 12 (SF-12), and EQ-5D 3-6. These 
questionnaires were administered at 6-weeks and 3-months following the index 
procedure for post-operative comparison. The WOMAC, SF-12, and EQ-5D are 
completed entirely by the patients and do not require any assistance from 
health care personnel. Unblinded physicians or health care personnel other 
than the treating surgeon completed the HHS. Any incomplete questionnaires 
were not included in final statistical analyses. An anterior-posterior pelvis and 
lateral hip radiograph were taken at the 6-week follow-up appointment to 
assess implant positioning, and document any peri-prosthetic concerns (i.e. 
fracture). 
 
Each patient also completed a Timed up-and-go (TUG) test pre-operatively and 
at the 6-week and 3-month post-operative intervals. The test begins with the 
patient sitting in a chair with armrests. On the word “Go”, the patient walks to a 
3-metre mark, turns, returns to the chair, and sits down 7. The time from the 
word “Go” to the instant the patient’s buttock contacts the chair is recorded to 
the nearest tenth of a second. The patient performs the test in their normal 
footwear and is allowed to use an assisted device (i.e. cane). A time greater 
than 10 seconds pre-operatively correlates with requiring a gait aid at 6-months 
following THA 8. A time of 10 seconds also correlates with increased risk of falls 
and inability to perform activities of daily living independently in patients with hip 
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osteoarthritis 9. A minimally important difference of 1.4 seconds has been 
reported in a population of patients living with hip arthritis 10. 
  
Several other parameters will be compared between the surgical approaches. 
Post-operative infections, peri-prosthetic fractures and dislocations, wound 
complications, nerve palsies, and medical complications (i.e. myocardial 
infarction or pulmonary embolism) are examples of complications used to 
differentiate the three approaches. These were collected prospectively during 
each hospital stay by means of a standardized In-hospital Stay Data Collection 
Sheet (Appendix C). 
  
3.2.4 Operative procedures 
A single surgeon was designated to perform every case using one of the three 
surgical approaches. There were no cases performed by trainees (i.e. residents 
or fellows). Each patient received standardized implants: a hydroxyapatite-
coated, cementless femoral stem (Corail TM stem, DePuy Orthopaedics Inc., 
Warsaw, IN), a cementless acetabular cup (Pinnacle Sector II TM acetabular 
cup, DePuy Orthopaedics Inc., Warsaw, IN), a highly cross-linked polyethylene 
liner (AltrX TM polyethylene liner, DePuy Orthopaedics Inc., Warsaw, IN), and a 
cobalt chrome femoral head (Articul/eze TM cobalt chrome, DePuy Orthopaedics 
Inc., Warsaw, IN). Cancellous screws (DePuy Orthopaedics Inc., Warsaw, IN) 
were inserted in order to augment acetabular fixation at the surgeon’s 
discretion. 
 
The anterior approach was performed using a modified Hueter approach 11. The 
patient was positioned supine on a specialized operating table (Hana TM fracture 
table, Mizuho OSI, Union City, CA). An incision was made 2 centimeters lateral 
to the anterior superior iliac spine, extending distally towards the superolateral 
patella for 8 to 10 centimeters. The superficial inter-nervous interval between 
tensor fascia latae and sartorius was incised, protecting the lateral femoral 
cutaneous nerve. The deep inter-nervous interval between gluteus medius and 
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rectus femoris was then incised, exposing the anterior joint capsule. A 
longitudinal capsulotomy was performed along the long axis of the femoral 
neck, extending from the acetabulum to the intertrochanteric line. Using a 
reciprocating saw, a femoral neck osteotomy was performed with appropriate 
soft tissue retractors in place. A corkscrew was used to remove the femoral 
head, and a napkin ring osteotomy of the femoral neck was used as needed to 
facilitate femoral head removal. The operative leg was then carefully externally 
rotated to aid in visualizing the acetabulum. Intra-operative fluoroscopy was 
used to verify inclination and anteversion during acetabular reaming. For 
femoral preparation, the operative leg is carefully extended, adducted, and 
externally rotated. A femoral bone hook on a motorized bracket was used to aid 
in visualizing the proximal metaphysis during preparation. Intra-operative 
fluoroscopy was used to verify stem size, femoral offset, and restoration of leg 
lengths. The wound was irrigated and closed in layers. 
 
The lateral approach was performed using the technique described by Hardinge 
12
. The patient was positioned in the lateral decubitus position. An incision was 
fashioned centered over the tip of the greater trochanter, extending 3 
centimeters proximally and 5 centimeters distally. The fascia latae was incised 
in line with the skin incision. A one-half anterior, one-half posterior split was 
made in the gluteus medius muscle. A tenotomy of the tendinous insertion of 
gluteus medius was performed, leaving a cuff of tissue for repair at the end of 
the case. The gluteus minimus and joint capsule were then dissected off the 
femoral neck in a single layer. The hip was then dislocated with the operative 
limb placed in a sterile bag. A femoral neck osteotomy was performed 1 
centimeter proximal to the lesser trochanter. This then provided adequate 
visualization of both the acetabulum and femur for preparation, which were 
performed in the usual fashion. The wound is thoroughly irrigated and closed in 
layers. Careful attention was taken when closing the gluteus medius tenotomy 
to prevent post-operative abductor insufficiency. 
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The posterior approach utilized the technique popularized by Moore 13.  The 
patient was positioned in the lateral decubitus position. A skin incision extended 
along the posterior aspect of the greater trochanter, curving towards the 
posterior superior iliac spine. The fascia overlying the gluteus maximus was 
incised in line with the skin incision. The gluteus maximus was bluntly dissected 
down to the short external rotators. The surgeon protected the sciatic nerve with 
soft tissue retraction without formal exploration. The conjoint tendon (superior 
and inferior gemelli and obturator internus) and piriformis were dissected off the 
greater trochanter and tagged with a suture for later repair. A capsulotomy was 
performed, followed by femoral neck osteotomy. This provided adequate 
exposure to perform both the acetabular and femoral reconstructions. The joint 
capsule and short external rotators are repaired through trans-osseous tunnels 
in the greater trochanter. The remainder of the wound is closed in layers. 
 
3.2.5 Post-operative care 
Post-operatively, all patients were admitted to an orthopedic ward. Each patient 
received 24 hours of post-operative antibiotics, as well as prophylaxis against 
deep vein thrombosis. Analgesia was managed by our institution’s acute pain 
service. All patients were permitted to weight-bear as tolerated with the use of a 
gait aid as needed. All patients received standardized, unblinded physiotherapy 
in accordance with our institution’s hip arthroplasty discharge pathway. 
  
3.2.6 Sample size calculation 
There are few studies comparing validated clinical outcome measures using 
different surgical approaches in THA. Restrepo et al. found an effect size of 
0.67 with the WOMAC questionnaire at 6-weeks as their primary endpoint 
between the anterior and lateral approach 14. To take a conservative approach 
we used an effect size of 0.60, alpha set at 0.05, and a power of 0.80.  This 
results in 36 participants in all groups.  To account for attrition, we inflated the 
sample size by 10%. Therefore, we will enroll 40 patients per group. 
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3.2.7 Statistical analysis 
The association between the anterior, posterior, and lateral approaches and 
demographic categorical data such as sex and operative side were evaluated 
by means of a nonparametric Pearson Chi-square. A one-way analysis of 
variance (ANOVA) was performed for continuous demographic variables such 
as age and BMI.  
 
The mean ranks of the domains of the EQ-5D pre-operatively and at each 
follow-up time point was evaluated the Kruskal-Wallis test. Those comparisons 
demonstrating statistical significance were then followed by post hoc, pair-wise 
testing using the Mann-Whitney test.  
 
A one-way ANOVA was used to compare pre-operative, 6-week, and 3-month 
outcome measures (HHS, WOMAC, SF-12, EQ-5D VAS and utility index, and 
TUG) across the 3 surgical approaches. Post-hoc analysis was performed using 
the Scheffé test to determine significant differences between the groups when 
necessary. Statistical significance was set at p<0.05. The SPSS® v.22 (SPSS 
Inc, Chicago, IL, USA) was used for all analyses. 
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3.3 Results 
3.3.1 Patient demographics 
Figure 3.1 represents a flow diagram outlining recruitment, patient exclusions, 
and follow-up. Sixty patients were excluded after random assignment for 
reasons listed in the flow diagram. All groups had complete pre-operative 
outcome measure data. Table 3.2 outlines the number of patients with missed 
follow-up at the 6-week and 3-month time-points, and reasons for the missed 
appointments. 
 
Patient demographics of the 118 patients enrolled in the study are outlined in 
Table 3.3. There were no statistically significant differences between the groups 
with regards to age and BMI following a one-way ANOVA. Sex, operative side, 
and primary diagnosis distributions were also not statistically different following 
Pearson Chi-square analysis.  
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Figure 3.1 – Flow diagram for study 
Complete Data 
(Outcomes, TUG): 
- Pre-op = 40 
- 6-weeks =  37 
- 3-months = 36 
  
Complete Follow-up Data 
(Outcomes, TUG): 
- Pre-op = 38 
- 6-weeks = 34  
- 3-months = 26  
Complete Follow-up Data 
(Outcomes, TUG): 
- Pre-op = 40 
- 6-weeks = 36 
- 3-months = 36  
178 Patients Assigned to 3 Approaches 
60 Patients Excluded: 
- BMI > 40 kg/m2 = 7 
- Acetabular dysplasia / developmental dysplasia = 7 
- Unable to walk unassisted for TUG = 7 
- Inflammatory arthropathy = 6 
- Post-traumatic arthritis = 5 
- Previous hip surgery = 5 
- Cognitively impaired = 4 
- Non-English speaking = 4 
- Declined participation = 4 
- Different implants used = 3 
- Simultaneous THA = 2 
- Other: 6 
Anterior Approach = 40 
Posterior Approach = 38 
Lateral Approach = 40 
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 Anterior Approach Posterior Approach Lateral Approach 
Number of patients 
with missed 6-week 
data 
n=3 
Reason: 
- 2 due to travel 
- 1 patient could not 
be contacted 
 
n=4 
Reason: 
- 2 due to travel 
- 2 patients could not 
be contact 
n=4 
Reason: 
- 1 due to travel 
- 3 patients could 
not be contacted 
Number of patients 
with missed 3-month 
data 
n=4 
Reason: 
- 3 patients still 
require 3-month 
follow-up 
- 1 patient could not 
be contacted 
n=12 
Reason: 
- 2 due to travel 
- 2 patients refused 3-
month follow-up 
- 2 patients could not 
be contacted 
- 6 patients still require 
3-month follow-up 
n=4 
Reason: 
- 2 due to travel 
- 2 patients could 
not be contacted 
 
Table 3.2 – Missed follow-up appointments 
An outline of the reasons for missing data at the 6-week and 3-month follow-up 
appointments. 
 
Demographic Anterior Approach Posterior Approach Lateral Approach p-
value 
Age (years) Mean = 66.9 
Std. Dev. = 9.5 
Range = 42 - 86 
Mean = 66.7 
Std. Dev. = 9.2 
Range = 44 - 84 
Mean = 65.5 
Std. Dev. = 10.4 
Range = 42 – 92 
0.792 
Sex Female = 25 
Male = 15 
Female = 24 
Male = 14 
Female = 26 
Male = 14 
0.971 
Body Mass 
Index (kg/m2) 
Mean = 27.9 
Std. Dev. = 4.3 
Range = 20.8 – 36.4 
Mean = 28.2 
Std. Dev. = 5.3 
Range = 16.2 – 39.9 
Mean = 29.1 
Std. Dev. = 5.6 
Range = 19.9 – 39.9 
0.541 
Operative 
Side 
Left = 22 
Right = 18 
Left = 18 
Right = 20 
Left = 18 
Right = 22 
0.647 
Primary 
Diagnosis 
Osteoarthritis = 37 
Avascular Necrosis = 3 
Osteoarthritis = 33 
Avascular Necrosis = 5 
Osteoarthritis = 38 
Avascular Necrosis = 2 
0.418 
 
Table 3.3 – Patient demographics 
 
Sample demographics with means, standard deviations, and ranges for 
continuous variables. 
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3.3.2 Clinical outcome measures 
 
3.3.2.1 Western Ontario and McMaster University   
  Osteoarthritis Index 
 
The results of the pre-operative, 6-week, and 3-month WOMAC can be found in 
Figure 3.3. The descriptive statistics from the comparison can be found in Table 
3.5. 
 
There were no statistically significant differences between the 3 groups for the 
pre-operative WOMAC pain, stiffness, function, and total score. At 6-weeks, 
there was a statistically significant difference between the groups for the 
function composite score, but not the pain, stiffness, and total score. Pair-wise 
post-hoc testing demonstrated that the anterior group scored higher than the 
lateral group on the 6-week function score (p=0.036). At 3-months, there were 
no statistically significant differences between groups for all of the WOMAC 
composite scores.  
Figure 3.2
Mean scores for each 
bars represent 95% confidence intervals. Pair
statistical significance for a given composite score are denoted by symbols.
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Anterior 
Approach (mean 
+/- SD) 
Posterior 
Approach (mean 
+/- SD) 
Lateral 
Approach 
(mean +/- SD) 
p-value 
Pre-operative 
WOMAC Pain 
45.8 +/- 19.1 43.4 +/- 20.0 46.4 +/- 21.0 0.818 
Pre-operative 
WOMAC Stiffness 
39.2 +/- 22.3 35.9 +/- 17.7 41.8 +/- 24.1 0.536 
Pre-operative 
WOMAC Function 
42.8 +/- 18.1 41.5 +/- 17.0 45.3 +/- 18.8 0.684 
Pre-operative 
WOMAC Total 
43.3 +/- 17.2 41.1 +/- 17.1 45.0 +/- 18.9 0.661 
6-week WOMAC 
Pain 
83.5 +/- 15.6 84.6 +/- 17.2 79.5 +/- 16.0 0.444 
6-week WOMAC 
Stiffness 
76.7 +/- 16.7 72.6 +/- 18.7 68.2 +/- 15.7 0.139 
6-week WOMAC 
Function 
86.9 +/- 12.9 81.1 +/- 16.8 77.2 +/- 14.1 0.036 
6-week WOMAC 
Total 
83.3 +/- 13.2 80.3 +/- 15.8 76.3 +/- 13.2 0.141 
3-month WOMAC 
Pain 
90.2 +/- 11.2 90.9 +/- 11.9 88.0 +/- 13.0 0.646 
3-month WOMAC 
Stiffness 
79.3 +/- 21.7 76.7 +/- 19.4 75.4 +/- 16.4 0.715 
3-month WOMAC 
Function 
89.2 +/- 10.0 89.4 +/- 11.4 87.1 +/- 12.4 0.680 
3-month WOMAC 
Total 
87.4 +/- 11.1 87.3 +/- 11.7 85.0 +/- 11.7 0.638 
 
Table 3.4 – Descriptive statistics for the WOMAC 
 
Descriptive statistics including means and standard deviations are outlined in 
the table, as well as the p-values for the one-way, between-group ANOVA for 
the WOMAC. 
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3.3.2.2 Harris hip score 
The results of the pre-operative, 6-week, and 3-month HHS can be found in 
Figure 3.2. The descriptive statistics for the ANOVA can be found in Table 3.4. 
 
There were no statistically significant differences between the 3 groups for the 
pre-operative Harris hip pain, function, and total score. At 6-weeks, there was a 
statistically significant difference between the groups for the function score, but 
not the pain and total scores. Post-hoc pair-wise testing demonstrated that the 
posterior approach cohort scored significantly higher on the 6-week function 
score (p=0.037) than the lateral approach group. The 6-week functional score 
for the anterior approach group nearly reached statistical significance when 
compared to the lateral approach group (p=0.057). Finally, at 3-months, there 
were no statistically significant differences between the 3 groups for all of the 
HHS composite scores. 
 
Figure 3.3
Mean scores for each component score for the Harris hip score at all time 
points. Error bars represent 95% confidence intervals. Pair
reaching statistical significance for a given composi
symbols. 
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Anterior 
Approach (mean 
+/- SD) 
Posterior 
Approach (mean 
+/- SD) 
Lateral 
Approach 
(mean +/- SD) 
p-value 
Pre-operative 
HHS Pain 
20.0 +/- 7.3 18.4 +/- 6.8 18.6 +/- 8.8 0.642 
Pre-operative 
HHS Function 
28.2 +/- 7.1 27.3 +/- 8.7 28.9 +/- 9.9 0.760 
Pre-operative 
HHS Total 
54.4 +/- 12.3 51.5 +/- 14.8 52.8 +/- 17.8 0.738 
6-week HHS Pain 41.3 +/- 4.5 41.6 +/- 4.7 42.6 +/- 2.9 0.430 
6-week HHS 
Function 
39.6 +/- 7.6 40.7 +/- 6.9 35.0 +/- 6.8 0.017 
6-week HHS Total 89.6 +/- 11.3 90.8 +/- 9.5 86.0 +/- 8.4 0.228 
3-month HHS 
Pain 
42.7 +/- 4.5 41.3 +/- 7.2 43.6 +/- 1.2 0.208 
3-month HHS 
Function 
42.9 +/- 5.7 42.1 +/- 6.6 41.1 +/- 6.4 0.494 
3-month HHS 
Total 
94.6 +/- 8.8 91.9 +/- 10.4 93.6 +/- 6.5 0.535 
 
Table 3.5 – Descriptive statistics for Harris hip score 
 
Descriptive statistics including means and standard deviations are outlined in 
the table, as well as the p-values for the one-way, between-group ANOVA for 
the HHS. 
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3.3.2.3 Short-form 12 
 
The results of the pre-operative, 6-week, and 3-month SF-12 Mental and 
Physical Component Summary scores (MCS and PCS, respectively) can be 
found in Figure 3.4. The descriptive statistics for this comparison can be found 
in Table 3.6. There were no statistically significant differences between the 
groups for any time point for the MCS and PCS scores of the SF-12. 
  
  
Mean scores for each component score for the SF
bars represent 95% confidence intervals
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Figure 3.4 – Results of SF-12 
 
-12 at all time points. Error 
. 
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Anterior 
Approach (mean 
+/- SD) 
Posterior 
Approach (mean 
+/- SD) 
Lateral 
Approach 
(mean +/- SD) 
p-value 
Pre-operative SF-
12 – MCS 
53.4 +/- 10.2 49.7 +/- 13.2 51.5 +/- 11.5 0.468 
Pre-operative SF-
12 – PCS 
30.7 +/- 7.4 31.0 +/- 9.1 31.2 +/- 7.8 0.975 
6-week SF-12 – 
MCS 
57.2 +/- 7.0 55.4 +/- 9.1 53.6 +/- 10.0 0.280 
6-week SF-12 – 
PCS 
40.8 +/- 10.4 35.9 +/- 9.8 35.8 +/- 8.8 0.087 
3-month SF-12 – 
MCS 
56.5 +/- 6.6 54.5 +/- 11.2 58.7 +/- 5.7 0.150 
3-month SF-12 – 
PCS 
45.4 +/- 9.9 47.1 +/- 10.2 44.2 +/- 8.3 0.554 
 
Table 3.6 – Descriptive statistics for the SF-12 
 
Descriptive statistics including means and standard deviations are outlined in 
the table, as well as the p-values for the one-way, between-group ANOVA for 
the SF-12. 
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3.3.2.4 EQ-5D 
 
The results outlining the pre-operative, 6-week, and 3-month dimension 
distributions for the EQ-5D questionnaire can be found in Tables 3.7, 3.8, and 
3.9, respectively. Pair-wise Mann-Whitney tests revealed that the pre-operative 
distribution of self-care was significantly different for the anterior versus 
posterior approach (p=0.008). At 6-weeks, the distribution of usual activities 
was significantly different for the anterior versus posterior (p=0.044) and 
anterior versus lateral (p=0.007) comparisons. At 3-months, the distribution of 
anxiety and depression was significantly different for the anterior versus lateral 
(p=0.018) and posterior versus lateral (p=0.004) comparisons. 
 
The results of the pre-operative, 6-week, and 3-month EQ-VAS and EQ-5D 
utility index can be found in Figures 3.5 and 3.6. The descriptive statistics for 
these comparisons can be found in Tables 3.10 and 3.11. There were no 
statistically significant differences between the groups for any time point for EQ-
VAS and utility index. 
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EQ-5D Dimension Anterior 
Approach 
Posterior 
Approach 
Lateral 
Approach 
Kruskal-
Wallis test 
Mobility 
Level 1 
Level 2 
Level 3 
 
7.5% 
90.0% 
2.5% 
 
11.1% 
86.1% 
2.8% 
 
7.7% 
92.3% 
0.0% 
 
0.887 
Self-Care 
Level 1 
Level 2 
Level 3 
 
45.0% 
55.0%  
0.0% 
 
75.0%  
25.0% 
0.0% 
 
56.4% 
43.6% 
0.0% 
 
0.030 
Usual Activities 
Level 1 
Level 2 
Level 3 
 
7.5% 
77.5% 
15.0% 
 
2.8% 
77.8% 
19.4% 
 
10.3% 
74.4% 
15.4% 
 
0.566 
 
Pain / Discomfort 
Level 1 
Level 2 
Level 3 
 
2.5% 
55.0% 
42.5% 
 
2.8% 
50.0% 
47.2% 
 
1.7% 
56.5% 
41.7% 
 
0.713 
Anxiety / 
Depression 
Level 1 
Level 2 
Level 3 
 
 
57.5% 
40.0% 
2.5% 
 
 
47.2% 
47.2% 
5.6% 
 
 
64.1% 
28.2% 
7.7% 
 
 
0.414 
 
Table 3.7 – Pre-operative EQ-5D dimension distribution 
 
Percent distributions across the 3 surgical approaches for pre-operative Level 1 
(no problems), Level 2 (some problems), and Level 3 (severe problems) 
responses for the EQ-5D dimensions. Refer to the text for pair-wise 
comparisons when significance on the Kruskal-Wallis test is less than 0.05. 
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EQ5D Dimension Anterior 
Approach 
Posterior 
Approach 
Lateral 
Approach 
Kruskal-
Wallis test 
Mobility 
Level 1 
Level 2 
Level 3 
 
64.9% 
35.1% 
0.0% 
 
50.0% 
50.0% 
0.0% 
 
55.6% 
44.4% 
0.0% 
 
0.461 
Self-Care 
Level 1 
Level 2 
Level 3 
 
89.2% 
10.8% 
0.0% 
 
80.0% 
20.0% 
0.0% 
 
77.8% 
22.2% 
0.0% 
 
0.403 
Usual Activities 
Level 1 
Level 2 
Level 3 
 
51.4%  
43.2% 
5.4% 
 
26.7% 
63.3% 
10.0% 
 
16.7% 
80.6%  
2.8% 
 
0.017 
Pain / Discomfort 
Level 1 
Level 2 
Level 3 
 
2.5% 
55.0% 
42.5% 
 
2.8% 
50.0% 
47.2% 
 
1.7% 
56.5% 
41.7% 
 
0.512 
Anxiety / 
Depression 
Level 1 
Level 2 
Level 3 
 
 
57.5% 
40.0% 
2.5% 
 
 
47.2% 
47.2% 
5.6% 
 
 
64.1% 
28.2% 
7.7% 
 
 
0.383 
 
Table 3.8 – 6-week EQ-5D dimension distribution 
 
Percent distributions across the 3 surgical approaches for the 6-week Level 1 
(no problems), Level 2 (some problems), and Level 3 (severe problems) 
responses for the EQ-5D dimensions. Refer to the text for pair-wise 
comparisons when significance on the Kruskal-Wallis test is less than 0.05. 
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EQ5D Dimension Anterior 
Approach 
Posterior 
Approach 
Lateral 
Approach 
Kruskal-
Wallis test 
Mobility 
Level 1 
Level 2 
Level 3 
 
78.1% 
21.9% 
0.0% 
 
83.7% 
16.3% 
0.0% 
 
70.0% 
30.0% 
0.0% 
 
0.577 
Self-Care 
Level 1 
Level 2 
Level 3 
 
96.4% 
3.6% 
0.0% 
 
94.7% 
5.3% 
0.0% 
 
89.7% 
10.3% 
0.0% 
 
0.571 
Usual Activities 
Level 1 
Level 2 
Level 3 
 
67.9% 
32.1% 
0.0% 
 
68.4% 
26.3% 
5.3% 
 
65.5% 
34.5% 
0.0% 
 
0.983 
Pain / Discomfort 
Level 1 
Level 2 
Level 3 
 
64.3% 
35.7% 
0.0% 
 
68.4% 
26.3% 
5.3% 
 
48.3% 
51.7% 
0.0% 
 
 
0.365 
Anxiety / 
Depression 
Level 1 
Level 2 
Level 3 
 
 
82.1% 
17.9%  
0.0% 
 
 
73.7% 
26.3%  
0.0% 
 
 
100.0%  
0.0% 
0.0% 
 
 
0.021 
 
Table 3.9 – 3-month EQ-5D dimension distribution 
 
Percent distributions across the 3 surgical approaches for 3- month Level 1 (no 
problems), Level 2 (some problems), and Level 3 (severe problems) responses 
for the EQ-5D dimensions. Refer to the text for pair-wise comparisons when 
significance on the Kruskal-Wallis test is less than 0.05. 
 
 Figure 3.5 
Mean scores for visual analogue scale of the EQ
bars represent 95% confidence intervals.
 
  
 
Approach 
Pre-operative EQ-
VAS 
6-week EQ-VAS 
3-month EQ-VAS 
 
Table 3.10 
 
Descriptive statistics including means and standard deviations are outlined in 
the table, as well as the p
the EQ-VAS. 
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– Results of EQ-5D VAS 
 
-5D at all time points. Error 
 
Anterior 
(mean 
+/- SD) 
Posterior 
Approach (mean 
+/- SD) 
Lateral 
Approach 
(mean +/- 
66.5 +/- 20.4 66.4 +/- 20.6 68.3 +/- 17.9
82.3 +/- 11.7 80.5 +/- 12.3 78.3 +/- 10.9
84.8 +/- 12.0 87.1 +/- 10.6 83.6 +/- 11.4
– Descriptive statistics for the EQ
-values for the one-way, between-group ANOVA for 
6-weeks 3-months
EQ-VAS Results
 
 
SD) 
p-value 
 0.889 
 0.344 
 0.576 
-VAS 
Anterior
Posterior
Lateral
 Figure 3.6 
Mean scores for the EQ
95% confidence intervals.
 
 
Anterior 
Approach (mean 
+/- 
Pre-operative 
EQ-5D utility 
index 
0.546 +/
6-week EQ-
5D utility 
index 
0.822 +/
3-month EQ-
5D utility 
index 
0.868 +/
 
Table 3.11 – Descriptive statistics for the EQ
Descriptive statistics including means and standard deviations are outlined in 
the table, as well as the p
the EQ-5D utility index.
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– Results of EQ-5D utility index
 
-5D utility index at all time points. Error bars rep
 
SD) 
Posterior Approach 
(mean +/- SD) 
Lateral 
Approach 
(mean +/-
- 0.190 0.538 +/- 0.200 0.572 +/- 0.192
- 0.136 0.763 +/- 0.142 0.756 +/- 0.086
- 0.124 0.861 +/- 0.174 0.845 +/- 0.111
-5D utility index
 
-values for the one-way, between-group ANOVA for 
 
 
6-weeks 3-months
-5D Utility Index Results
 
 
 
resent 
 SD) 
p-
value 
 0.737 
 0.051 
 0.811 
 
Anterior
Posterior
Lateral
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3.3.2.5 Timed up-and-go test 
 
The results of the pre-operative, 6-week, and 3-month TUG tests can be found 
in Figure 3.7. The descriptive statistics for this comparison can be found in 
Table 3.12. There were no statistically significant differences following a one-
way ANOVA between the groups for any time point for the TUG test. All group 
means fell under the 10-second benchmark predictive of performing activities of 
daily living independently after 3-months post-operatively 9. 
  
 Figure 3.7 
Mean times for the TUG test at all time points. Error bars represen
confidence intervals.  
 
 
Anterior 
Approach (mean 
+/- 
Pre-operative 
TUG test 
15.6 +/
6-week TUG 
test 
11.7 +/
3-month TUG 
test 
9.5 +/
 
Table 3.12 
Descriptive statistics including means 
the table, as well as the p
the TUG test. 
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– Results of the TUG test 
 
SD) 
Posterior Approach 
(mean +/- SD) 
Lateral 
Approach 
(mean +/-
- 5.7 16.8 +/- 10.6 16.7 +/- 
- 3.5 12.2 +/- 5.0 13.0 +/- 
- 2.4 9.0 +/- 2.4 9.5 +/- 3.0
– Descriptive statistics for the TUG test
 
and standard deviations are outlined in 
-values for the one-way, between-group ANOVA for 
 
-op TUG 6-week TUG 3-month TUG
Timed Up-and-go Results
 
 
t 95% 
 SD) 
p-
value 
9.3 0.783 
6.3 0.559 
 0.802 
 
Anterior
Posterior
Lateral
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3.3.3 Complications 
 
Table 3.13 provides a summary of the complications documented across all 
three cohorts. There was a statistically significant difference in the number of 
nerve palsies observed in THAs performed through an anterior versus lateral or 
posterior approach (p=0.001). All 7 cases were injury to the lateral femoral 
cutaneous nerve resulting in symptomatic paresthesia. All cases resolved with 
expectant management at 3-month follow-up. 
 
A single case of peri-prosthetic infection occurred in the anterior approach 
group. The patient was a 72 year-old male with a BMI of 35.56 kg/m2 and a 
primary diagnosis of avascular necrosis. He had a persistently draining wound 
post-operatively that did not abate with community dressing changes. His initial 
investigations included a leukocyte count of 4.8 x 10 9 / L, erythrocyte 
sedimentation rate (ESR) of 28 mm/h, and a C-reactive protein (CRP) of 2.3 
mg/L. The infection was diagnosed 18 days post-operatively. The patient was 
admitted to hospital and treated with removal of the femoral stem, femoral 
head, and polyethylene liner, irrigation and debridement, followed by 
implantation of a new Corail TM femoral stem, cobalt chrome femoral head, and 
highly cross-linked polyethylene liner. Intra-operative cultures grew 
Staphylococcus epidermidis. He received a 6-week course of intravenous 
cefazolin through a peripherally inserted central catheter. His latest ESR and 
CRP were 8 mm/h and 0.9 mg/L, respectively, 3-months following the irrigation 
and debridement.  
 
The peri-prosthetic fracture occurred in a lady following a fall from standing 
height onto the operative hip 11-weeks post-operatively. Plain radiographs 
diagnosed a minimally displaced Vancouver AL peri-prosthetic fracture based on 
the Vancouver classification 15. The fracture was treated non-operatively with 
weight-bearing restrictions and went on to heal without further complication. 
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The wound complication in the anterior approach group was a stitch abscess 
diagnosed 4-weeks post-operatively. It was successfully treated with an incision 
and drainage, community dressing changes, and 2 weeks of oral cephalexin. 
The patient in the lateral approach group had a small dehiscence of the 
proximal aspect of their incision that required community dressing changes to 
allow for healing through secondary intent. This patient received 10 days of oral 
cephalexin and required no further intervention. 
 
The complications occurring in the “Other” category were intra-operative injuries 
in the anterior approach group. One patient sustained an ipsilateral knee sprain 
during limb manipulation using the Hana TM fracture table. A post-operative 
radiograph ruled out fracture around the knee, and magnetic resonance 
imaging (MRI) did not identify any intra-articular or soft tissue injury. The patient 
was successfully treated with rehabilitation. The second case was an intra-
operative ankle sprain sustained during limb manipulation using the Hana TM 
fracture table. Plain radiographs did not identify any fracture, and this patient 
also recovered well with rehabilitation. There were no medical complications 
throughout all three cohorts. 
 
 
Anterior 
Approach 
(n=40) 
Posterior 
Approach 
(n=38) 
Lateral 
Approach 
(n=40) 
Pearson 
Chi-
square 
Nerve Palsy 7 (17.5%)  0 0 0.001 
Dislocations 0 0 0 1.000 
Peri-prosthetic 
Infections 
1 (2.5%) 0 0 0.388 
Peri-prosthetic 
Fracture 
0 1 (2.7%) 0 0.332 
Wound Complications 1 (2.5%) 0 1 (2.5%) 0.628 
Other 2 (5.0%) 0 0 0.148 
 
Table 3.13 – Summary of group complications 
 
A summary of complications diagnosed across all three surgical approach 
cohorts during the course of the study. Significant differences between group 
complication rates were identified with a Pearson Chi-square. 
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3.4 Discussion 
The purpose of this study was to determine whether surgical approach in THA 
has a significant impact on short-term clinical outcomes in a randomly assigned 
cohort. There were significant differences across the groups, primarily in 
functional composite scores, when comparing both disease-specific and generic 
clinical outcome measures. There were also significant differences in the 
complication rates post-operatively across the 3 surgical approaches. 
 
The anterior approach demonstrated superior functional scores on both a 
disease-specific (WOMAC) and generic (EQ-5D, usual activities dimension) 
outcome measure at 6-weeks versus the lateral approach. Both the WOMAC 
and EQ-5D, unlike the HHS, are patient-reported outcome measures. This 
reduces the chance of expectation bias, and thus committing a type I error, 
associated with physician-reported outcome measures. Other studies in the 
literature have supported this finding when comparing 6-week functional 
composite scores or activities across the 3 different surgical approaches 14, 16. 
Although the study was powered specifically on a WOMAC total score 
difference a priori, the WOMAC has demonstrated good content validity and 
internal consistency across the subscales (i.e. pain, stiffness, function), thus the 
differences are still clinically relevant 4.  
  
There are several reasons as to why the anterior approach may provide earlier 
functional benefit following a THA. The anterior approach has been deemed a 
“muscle-sparing” approach by several authors, as it avoids the need for a large 
muscle tenotomy (i.e. gluteus medius in the lateral approach) or intra-muscular 
dissection (i.e. gluteus maximus in the posterior approach) 17, 18. Cadaveric 
studies have demonstrated that less muscle damage occurs during an anterior 
versus posterior approach to the hip 19. This study is limited by the use of 
cadaveric specimens as muscle tissue would respond differently in-vivo, 
particularly during soft tissue retraction to facilitate surgical exposure. Patients 
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have reported that minimizing muscle damage during surgery would be a 
reason to choose a particular surgical approach over another 20. 
Psychologically, this may motivate patients to get up and mobilize sooner. 
Knowing that they have less muscle damage to protect during daily activities 
may expedite functional improvement detected on clinical outcome measures.  
 
Pain reduction following a THA performed through an anterior approach is 
another possible reason for earlier functional recovery. Goebel et al. studied 
pain perception, narcotic consumption, and length of stay in hospital in an 
anterior versus lateral THA cohort. They found that the anterior cohort reported 
significantly less post-operative pain on a visual analogue scale and less 
narcotic consumption following chart review, and shorter hospital stays 21. 
However, our study demonstrated no difference in composite pain scores 
across all of the clinical outcome measures. 
  
Another explanation for the difference may be related to the incidence of 
abductor tendon degeneration and atrophy following a THA through a lateral 
approach. Bremer et al. examined the abductor complex using MRI following 
THA and found a higher incidence of abductor tendinosis and gluteus medius 
muscle atrophy in patients having a lateral versus anterior approach at one-year 
post-operatively 22. Abductor insufficiency can cause functional limitations and 
increased pain post-operatively 23, 24. It is likely that the abductor insufficiency 
complicates certain functional activities (i.e. ascending and descending stairs), 
thus the discrepancy is reflected in early (6-week) functional scores rather than 
pain scores. This may explain why the posterior approach, which spares the 
abductor complex, also outperformed the lateral approach on a functional 
composite score. It is also important to note that 20% of patients with hip 
osteoarthritis may have abductor insufficiency at the time of THA 25, however, 
all cohorts performed similarly across pain and functional composite scores pre-
operatively in our study. Finally, there were no significant differences at 3-
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months, which may be because 3-months is the usual duration of musculo-
tendinous healing 26, or patients have learned to adapt to functional limitations. 
 
There were significantly more complications in the anterior approach cohort 
throughout the study. The incidence of 17.5% for lateral femoral cutaneous 
nerve palsies falls within ranges reported in the literature 27. The high number of 
nerve palsies is likely due to the nerve’s variable course around the anterior 
superior iliac spine during superficial dissection, resulting in iatrogenic injury, or 
during rigorous soft tissue retraction required during femoral or acetabular 
exposure, resulting in a tension neuropraxia 17. Our study suggests that 
although injury to lateral femoral cutaneous nerve is common with an anterior 
approach, it has no detrimental effect on pain or function following a THA. As 
well, caution needs to be exercised when using a specialized table for the 
anterior approach. Two complications (an ankle and knee sprain) occurred as a 
direct result of limb manipulation using this table, which have also been 
described by other authors well versed in using the anterior approach 17. 
 
Our study is not without limitations. It is difficult to perform a randomized, 
controlled trial using surgical procedures as the intervention. It would not of 
been ethical to randomize patients to one of the three approaches after they 
had established rapport with their assigned surgeon. This does introduce 
selection bias into the study design; fortunately, our groups were relatively 
homogeneous. This would require a multi-centre, multi-surgeon study where all 
surgeons were proficient in all three surgical approaches.  Loss to follow-up is 
an obvious limitation, increasing the chance of a type II error, especially with a 
small sample size. However, we did account for 10% loss in our sample size 
calculation, which allowed for adequate numbers in the anterior and lateral 
groups at all time points. Every effort was taken to find out the reason for the 
missed appointment in order to complete the data. Once all patients have 
completed the required follow-up, imputation of mean values or regression will 
be used to complete missing data. The follow-up period was also relatively 
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short. However, as discussed earlier, the purported functional advantages of 
the anterior approach occur in the first 6-weeks to 3-months in many studies, 
thus we felt this was a long enough time duration to satisfy our hypothesis. 
Lastly, the external validity of the study is limited by each approach being 
performed by a single surgeon from a single institution. This also introduces 
performance bias as some surgeons are more proficient at certain procedures 
than others; however, our study was designed to optimize internal validity. 
  
Our study has several strengths. Perhaps the most important was that every 
patient in this study received standardized implants (see Appendix D). Femoral 
stem design, femoral and acetabular fixation (cementless versus cemented), 
and bearing surfaces can all influence clinical outcomes. For instance, 
cylindrical, extensively porous-coated femoral stems are known to cause an 
increased incidence of anterior thigh pain, which can then influence pain 
composite scores on various outcome measures 28, 29. To our knowledge, 
standardization of all components has not been described in any other study 
examining the effects of surgical approach on THA outcomes. We also chose to 
use validated disease-specific and generic clinical outcome measures. This 
allowed us to gauge not only the effect of the intervention in mitigating pain and 
dysfunction associated with hip arthritis, but also the effect of the disease 
process and intervention on emotional and mental health.  
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3.5 Conclusion 
This study examined the effect of surgical approach in THA on validated, 
disease-specific and generic clinical outcome measures using standardized 
implants. The anterior approach demonstrated superior functional outcomes at 
6-weeks when compared to the lateral approach, but not the posterior 
approach. Complication rates, specifically lateral femoral nerve palsies, were 
significantly higher in the anterior approach group. Further research directions 
include using imaging modalities such as MRI to diagnose muscle damage and 
tendinosis following THA, and correlating these findings with changes seen in 
daily activities such as gait analysis. As well, the impact of surgical approach on 
component positioning and revision rates was not addressed in this study, but is 
an area of interest. All three surgical approaches produce positive changes that 
exceed the minimally important difference across various clinical outcome 
measures. 
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Chapter 4 
 
4 Surgical approach in total hip arthroplasty: A cost- 
analysis 
 
4.1 Introduction 
 
Total hip arthroplasty (THA) is a commonly performed surgical procedure for 
the treatment of hip arthritis. Approximately 50,000 THAs are performed on an 
annual basis in Canada 1. The costs incurred to the healthcare system are 
tremendous, amounting to anywhere between 4.3 and 7.3 billion dollars each 
year (1994 Canadian dollars) 2. Despite the substantial financial burden of THA 
on healthcare economics in Canada, few studies have provided accurate cost 
estimations of this procedure 2, 3. 
  
Total hip arthroplasty has been the subject of cost-analysis studies. When 
comparing the procedure to non-operative treatment of hip osteoarthritis, THA 
is cost-effective, and in some instances, cost-saving 4. Other studies have 
examined the impact of different bearing articulations, stem designs, and 
fixation methods on cost-effectiveness in THA 5-7. However, these studies have 
relied on retrospective analyses of costs, and the perspective of the analyses 
has been unclear. Also, the impact of surgical approach on costs following THA 
has not been fully elucidated. 
 
The purpose of this study was to determine the impact of surgical approach on 
costs in THA. This prospectively designed study will provide an accurate 
representation of costs following this intervention from a Canadian institution. 
Our hypothesis was that surgical approach would not result in significant 
differences in costs in patients undergoing THA. 
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4.2 Materials and Methods 
 
4.2.1 Study framework 
Institutional review board ethics approval was attained at Western University. 
Patients were recruited as per the patient enrolment and selection protocol 
outlined in Chapter 3. All patients were recruited from a single institution 
through University Hospital at Western University. A total of 118 patients were 
recruited to partake in the study. Patients were followed prospectively in order 
to provide accurate assessments of cost in patients undergoing a THA through 
either an anterior, posterior, or lateral approach. Each procedure was 
performed as outlined in Chapter 3, with all patients receiving standardized 
implants. 
 
4.2.2 Study perspective 
The goal of this study is to determine the impact of surgical approach on total 
costs for THA from a hospital, or ministry of health, perspective. 
  
4.2.3 Boundaries of the analysis 
This study’s goal was to provide a cost-analysis that would impact clinical 
practice in both academic and community settings in Canada. Therefore, the 
inclusion and exclusion criteria (Table 3.1) were thought to represent the most 
common patient population undergoing a THA. Only THAs performed through 
either an anterior, posterior, or lateral approach were included.  
 
4.2.4 Time horizon for the study 
The time horizon for the cost-analysis included the time of admission to hospital 
to time of discharge from hospital following the procedure. The official time to 
admission and discharge was extracted from each patient’s electronic medical 
record.  
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4.2.5 Determining costs 
All costs throughout this study were acquired prospectively. A micro-costing 
method was used to determine all costs throughout the study. Dollar values are 
disseminated in 2013 Canadian dollars.  
 
4.2.5.1 Operating room costs 
The cost of the operating room time was calculated from the moment the 
patient entered the room, to the time they left the room to recover in the post-
anesthetic care unit (PACU). A per minute direct and indirect operating room 
cost was acquired from the costing department at London Health Sciences 
Centre (LHSC). Costs applicable to the billing surgeon and anesthetist were 
acquired through the Ontario Ministry of Health’s schedule of benefits 8. The 
Inventory Control Clerk for LHSC provided the cost of implants and operating 
room supplies such as drapes and sutures.  
 
There were some items that were utilized specifically for the anterior approach. 
Intra-operative fluoroscopy was monetized on a per minute basis, capturing the 
direct and indirect costs of the technician and use of the C-arm fluoroscopic 
machine. The cost of the radiologist reading the film post-operatively was 
acquired from the Ontario Ministry of Health’s schedule of benefits 8. Lead 
aprons were required during all anterior approach procedures in order to protect 
against fluoroscopic radiation. The cost of each lead apron was distributed on a 
per case basis using 1-year as the longevity of the item. At least seven 
personnel would require an apron during each case: surgeon, surgical assistant 
/ clinical fellow, resident / medical student, anesthesia consultant, scrub nurse, 
circulating nurse, and x-ray technician. Approximately 130 anterior approach 
THAs are performed annually, resulting in the following calculation: 
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  $700 per apron x 7 personnel = $4900 per year on aprons  
  $4900 per year / 130 anterior cases per year = $37.70 per case  
 
The traction table (Hana TM fracture table, Mizuho OSI, Union City, CA) was also 
incorporated into the final cost. The longevity of the table is 5-years as 
recommended by the manufacturer, resulting in the following calculation: 
 
  $120,000 per table / 5-year longevity = $24,000 per year 
  $24,000 per year / 130 anterior cases per year = $185 per case 
 
Appendix E outlines an example of all of the costs captured during each 
operating room visit. 
  
4.2.5.2 In-hospital costs 
Following each operation, the patient would then be admitted to the PACU. 
Patient care and resource utilization costs in the PACU were represented on a 
per minute basis in consultation with the LHSC costing department. The length 
of each PACU admission was determined as the time leaving the operating 
room, to the time of admission to the inpatient ward. This information was 
gathered from paper and electronic chart review. 
 
Following discharge from the PACU, the patient is admitted to the inpatient 
orthopedic ward. All patients received 24 hours of post-operative antibiotics, as 
well as deep vein thrombosis prophylaxis. Nursing care costs were based on an 
average per hour wage at LHSC. Administered medications, care items (i.e. 
dressing changes, urinary catheterizations), and investigations performed were 
recorded from paper and electronic chart review prospectively throughout each 
patient’s admission using an In-hospital Stay Data Collection Sheet (see 
Appendix C). These costs were acquired from the costing department and 
pharmacy at LHSC. The Ministry of Health’s schedule of benefits was used to 
determine costs for consultations from other physicians (i.e. acute pain 
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services, internal medicine, infectious diseases, radiology). Allied health 
resources such as physiotherapy, occupational therapy, and social work were 
assigned a per-hour cost based on information from the costing department at 
LHSC. The time allotted for each allied health assessment was retrieved from 
paper chart review.  
 
The total length of stay in hospital, including time in the operating room, was 
recorded from the patient’s electronic chart. The in-hospital costs represented 
the sum of time spent in day surgery pre-operatively, time spent in PACU, plus 
time on the inpatient orthopedic ward.  Appendix F provides a summary of the 
information captured during each hospital stay. 
 
4.2.6 Statistical analysis 
The association between the anterior, posterior, and lateral approaches and 
categorical data were evaluated by means of a nonparametric Pearson Chi-
square. A one-way analysis of variance (ANOVA) was performed for continuous 
demographic variables such as age and body mass index (BMI). 
 
A one-way ANOVA was used to compare various hospital metrics and cost data 
across the 3 surgical approaches, including operating room time, operating 
room costs, in-hospital costs, hospital length of stay, and total costs of the 
procedure. Post-hoc analysis was performed using the Scheffé test to 
determine significant differences between the groups when necessary. 
Statistical significance was set at p<0.05. The SPSS® v.22 (SPSS Inc., 
Chicago, IL, USA) was used for all analyses. 
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4.3 Results 
4.3.1 Patient demographics 
Figure 4.1 is a flow diagram outlining patient recruitment, exclusions, and 
completeness of intra-operative and in-hospital stay data. All 118 patients 
currently participating in the study had complete intra-operative and in-hospital 
data. Table 4.1 demonstrates patient demographics, including descriptive 
statistics for continuous variables. There were no statistically differences 
between the groups with regards to age and BMI following a one-way ANOVA. 
Sex, operative side, and primary diagnosis distributions were also not 
statistically different following Pearson Chi-square analysis.  
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Figure 4.1 – Flow diagram for study 
 
 
 
Completed data: 
- Intra-operative: 40 
- In-hospital: 40  
178 Patients Assigned to 3 Approaches 
60 Patients Excluded: 
- BMI > 40 kg/m2 = 7 
- Acetabular dysplasia / DDH = 7 
- Unable to walk unassisted for TUG = 7 
- Inflammatory arthropathy = 6 
- Post-traumatic arthritis = 5 
- Previous hip surgery = 5 
- Cognitively impaired = 4 
- Non-English speaking = 4 
- Declined participation = 4 
- Different implants used = 3 
- Simultaneous THA = 2 
- Other: 6 
Anterior Approach = 40 
Posterior Approach = 38 
Lateral Approach = 40 
Completed data: 
- Intra-operative: 40 
- In-hospital: 40  
Completed data: 
- Intra-operative: 38 
- In-hospital: 38  
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Demographic Anterior Approach Posterior Approach Lateral Approach p-
value 
Age (years) Mean = 66.9 
Std. Dev. = 9.5 
Range = 42 - 86 
Mean = 66.7 
Std. Dev. = 9.2 
Range = 44 - 84 
Mean = 65.5 
Std. Dev. = 10.4 
Range = 42 – 92 
0.792 
Sex Female = 25 
Male = 15 
Female = 24 
Male = 14 
Female = 26 
Male = 14 
0.971 
Body Mass 
Index (kg/m2) 
Mean = 27.9 
Std. Dev. = 4.3 
Range = 20.8 – 36.4 
Mean = 28.2 
Std. Dev. = 5.3 
Range = 16.2 – 39.9 
Mean = 29.1 
Std. Dev. = 5.6 
Range = 19.9 – 39.9 
0.541 
Operative 
Side 
Left = 22 
Right = 18 
Left = 18 
Right = 20 
Left = 18 
Right = 22 
0.647 
Primary 
Diagnosis 
Osteoarthritis = 37 
Avascular Necrosis = 3 
Osteoarthritis = 33 
Avascular Necrosis = 5 
Osteoarthritis = 38 
Avascular Necrosis = 2 
0.418 
 
Table 4.1 – Patient demographics 
 
Sample demographics with means, standard deviations, and ranges for 
continuous variables. 
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4.3.2 Intra-operative time and costs 
The 3-group comparison for procedure time (time from cutting skin to wound 
closure) and total time in the operating room (time in room to time out of room) 
can be found in Figure 4.2. Descriptive statistics for procedure time, total time in 
the operating room, and time to position each patient in preparation for each 
procedure are included in Table 4.2.  
 
One-way ANOVA testing revealed statistically significant differences between 
the groups for procedure time, total time in the operating room, and patient 
positioning time. Post-hoc testing demonstrated significantly shorter procedure 
time for the lateral versus anterior and posterior approach (p=<0.001 and 
p<0.001, respectively). The procedure time was also significantly shorter for the 
posterior versus anterior approach (p=0.005). Total time in the operating room 
was significantly shorter for the lateral versus anterior and posterior approach 
(p<0.001 and p=0.008, respectively). Positioning time was significantly shorter 
for the anterior versus posterior approach (p=0.001).  
 
Intra-operative costs are disseminated in 2013 Canadian dollars for both the 
cost of the operating room time only (Figure 4.3), as well as the total procedural 
cost (Figure 4.4 and Table 4.3). A detailed breakdown of the costs acquired can 
be found in the Appendix C. One-way ANOVA testing revealed statistically 
significant differences between the groups for both operating room time costs 
and total procedural costs. Post-hoc testing determined that the cost of the 
operating room time was significantly less for the lateral versus anterior and 
posterior approach (p<0.001 and p=0.008, respectively). The total cost of the 
procedure was significantly less for the lateral versus anterior and posterior 
approach (p<0.001 and p=0.001, respectively), and the posterior versus 
anterior approach (p=0.008). 
  
Figure 4.2 – Procedure time and total operating room time
Mean procedure time and total operating room times for each surgical 
approach. Error bars represent 95% confidence intervals. Pair
comparisons with statistical significance are denoted by symbols
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Anterior 
Approach 
(mean +/- SD) 
Posterior 
Approach 
(mean +/- SD) 
Lateral 
Approach 
(mean +/- SD) 
p-value 
Procedure time 
(min) 
69.3 +/- 10.1 61.6 +/- 11.9 49.0 +/- 8.1 <0.001 
Total time in 
OR (min) 
105.7 +/- 11.8 99.6 +/- 17.9 87.7 +/- 18.8 <0.001 
Patient 
positioning 
time (min) 
11.2 +/- 3.8 15.1 +/- 5.5 12.9 +/- 4.2 0.001 
 
Table 4.2 – Descriptive statistics for intra-operative times 
 
Descriptive statistics including means and standard deviations are outlined in 
the table, as well as the p-values for the one-way, between-group ANOVA for 
various operating room metrics.
 Figure 4.3 
Mean cost of operating room time for each surgical approach. Error bars 
represent 95% confidence intervals. Pair
significance are denoted by symbols
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Anterior Approach 
(mean +/- SD) 
Posterior Approach 
(mean +/- SD) 
Lateral Approach 
(mean +/- SD) 
p-
value 
Cost of 
operating 
room time 
(2013 
Canadian 
dollars) 
 
$1729.90 +/- 193.10 
 
Range: $1407.82 – 
2062.62 
 
$1629.92 +/- 292.82 
 
Range: $1145.90 – 
2553.72 
 
$1435.24 +/- 307.70 
 
Range: $965.83 – 
2259.06 
 
<0.001 
Total cost 
of 
procedure 
(2013 
Canadian 
dollars) 
 
$5799.79 +/- 254.12 
 
Range: $5412.19 – 
6432.15 
 
$5560.24 +/- 362.36 
 
Range: $4959.43 – 
6577.39 
 
$5274.39 +/- 362.22 
 
Range: $4735.21 – 
6223.16 
 
<0.001 
 
Table 4.3 – Descriptive statistics for operating room costs 
 
Descriptive statistics including means, standard deviations, and ranges are 
outlined in the table, as well as the p-values for the one-way, between-group 
ANOVA for operating room and procedural costs. 
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4.3.3 Hospital length of stay and costs 
 
The 3-group comparison for hospital length of stay, as well as associated 
inpatient costs, can be found in Figures 4.5 and 4.6 and Table 4.4. One-way 
ANOVA testing demonstrated statistically significant group differences for 
hospital length of stay and total inpatient costs. Post-hoc testing revealed a 
statistically significant shorter length of stay for the anterior versus posterior and 
lateral approach (p<0.001 for both pair-wise comparisons). Length of stay was 
comparable between the posterior and lateral approach (p=0.952). The total 
inpatient costs were significantly less for the anterior versus lateral and 
posterior approach (p<0.001 for both pair-wise comparisons). Total inpatient 
costs were comparable between the posterior and lateral approach (p=0.729). 
 
Figure 4.5 
Mean hospital length of stay for each 
95% confidence intervals. Pair
are denoted by symbols
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Figure 4.6 
Mean total inpatient costs for each surgical approach. Error 
confidence intervals. Pair
denoted by symbols. 
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Anterior Approach 
(mean +/- SD) 
Posterior Approach 
(mean +/- SD) 
Lateral Approach 
(mean +/- SD) 
p-
value 
Hospital 
length of 
stay 
(hours) 
 
33.9 +/- 13.4 
 
Range: 24.9 – 98.4 
 
65.8 +/- 27.2 
 
Range: 29.1 – 171.4 
 
64.2 +/- 23.5 
 
Range: 30.5 – 144.8 
 
<0.001 
Total cost 
of 
inpatient 
stay (2013 
Canadian 
dollars) 
 
$1500.43 +/- 683.59 
 
Range: $1099.06 – 
4994.27 
 
$2727.22 +/- 998.28 
 
Range: $1255.88 – 
5865.66 
 
$2578.71 +/- 751.38 
 
Range: $1625.95 +/-
5008.66 
 
<0.001 
 
Table 4.4 – Descriptive statistics for length of stay and total 
       inpatient costs 
 
Descriptive statistics including means, standard deviations, and ranges are 
outlined in the table, as well as the p-values for the one-way, between-group 
ANOVA for hospital length of stay and total inpatient costs. 
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4.3.4 Total cost of total hip arthroplasty  
 
Figure 4.7 and Table 4.5 outline the total costs of a THA from a hospital 
perspective. One-way ANOVA testing revealed statistically significant 
differences between the 3 surgical approaches for total THA costs. The anterior 
approach cost significantly less than both the posterior and lateral approach 
following post-hoc testing (p<0.001 and p=0.031, respectively). The difference 
in costs between the lateral and posterior approach was not significant 
(p=0.124).  
  
 Figure 4.7 – Total cost of THA from 
Mean total costs of THA for each surgical approach from a hospital perspective. 
Error bars represent 95% confidence intervals. Pair
statistical significance are denoted by symbols.
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Table 4.5 – Descriptive statistics for total cost of THA
 
Descriptive statistics including means, standard deviations, and ranges are 
outlined in the table, as well as the p
ANOVA for the total costs of a THA from a hospital perspective.
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4.4 Discussion 
 
The purpose of this study was to determine the impact of surgical approach on 
costs associated with a THA from the perspective of a hospital. A micro-costing 
method was used to accurately capture costs of the procedure, as well as the 
inpatient stay. There were statistically significant differences between the 
groups for procedural costs, inpatient costs, and overall costs. There were also 
statistically significant differences in various hospital metrics such as operating 
room time and length of stay in hospital. 
 
The total cost of a THA from a hospital perspective was significantly less when 
performed using an anterior versus posterior or lateral approach. The mean 
cost savings per case when compared to the lateral and posterior groups 
amounts to approximately $550 to $1000, respectively. Over the course of a 
calendar year, that would amount to significant cost savings to a hospital.  
 
Some of the purported disadvantages of the anterior approach are the added 
costs associated with using a specialized operating room table, such as the 
Hana TM fracture table in this study, as well as costs of using intra-operative 
fluoroscopy. These factors, along with prolonged mean operating room time, 
contributed to increased procedural costs observed in the anterior group. 
Hospital administrators may be reluctant to implement such a procedure due to 
the expensive up-front costs of the specialized table ($120,000 in 2013 
Canadian dollars). Increased operating room time has been reported in other 
studies when comparing the anterior other surgical approaches 9, 10. Again, 
administrators may find it difficult to implement this approach at the expense of 
potentially completing fewer cases, or running the risk of paying hospital staff 
overtime for prolonged cases. 
  
However, a significant reduction in hospital length of stay translated into 
significant cost savings overall from a hospital perspective. Several other 
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studies have found that having a THA performed through an anterior approach 
results in a significant reduction in days spent in hospital 9-12. This may be due 
to many of the functional benefits of the anterior approach discussed in Chapter 
3. Future studies should examine the effect of the earlier discharge from 
hospital from a societal perspective. Patients leaving hospital earlier may 
require dependence on several outpatient resources such as community care 
nurses for dressing changes, outpatient physiotherapy referrals, and time 
invested from alternative caregivers. 
  
The mean costs reported in this study are higher than the previous reported 
mean costs of a THA performed in Canada by Antoniou in 2004. They reported 
mean costs of $6766 (2001 US dollars) from a hospital perspective, with 
implant costs contributing $1695 3. Interestingly, the mean length of stay was 
7.2 days in that study. Unfortunately, a detailed breakdown of the costs were 
not disseminated in this study, therefore it is impossible to determine whether 
most of the costs were contributed through the procedure (i.e. operating room 
time) or inpatient stay in hospital. All of the implants were standardized in the 
current study, amounting to $2450 (2013 Canadian dollars) per case. It is clear 
from the micro-costing method utilized in this study that most of the overall 
costs are contributed by the total cost of the procedure. 
 
Therefore, in order to reduce costs, hospital administrators need to look at 
either improving operating room efficiency or reducing the number of days 
patients spend in hospital. Examining the data closely, approximately 40 
minutes were spent in the operating room not operating on patients. This time 
would include time to administer and reverse the anesthetic, and patient 
positioning. Literature suggests that dedicated operating room units (i.e. 
anesthesia and nursing staff facile in a certain procedure) can reduce operating 
room time and patient turnover 13. Time spent waiting in the operating room due 
to patient turnover incurs tremendous costs, as the per minute rate for the 
operating room is substantially higher than that of the post-anesthetic care unit 
  156 
or orthopedic ward. Another factor to consider is day of surgery, as well as time 
of day when the surgery is performed. Surgery performed later in the day or on 
Fridays could reduce exposure to physiotherapy due to resource limitations. 
Dedicated rehabilitation protocols for specific procedures such as THA have 
been shown reduce length of stay 14. Finally, procedures that permit earlier 
functional independence and reduce post-operative pain, such as the anterior 
approach for THA, can reduce hospital length of stay 12, 15. 
  
The generalizability of the data is a limitation of this study. The cost data is 
taken from a single academic institution within a publically funded healthcare 
system, which would undoubtedly vary from one hospital to another and one 
healthcare model to another. As well, the anterior approach can be performed 
without the use of a specialized table or intra-operative fluoroscopy, which may 
have reduced costs even further 16. Furthermore, a single surgeon from a single 
academic institution performed each surgical approach. Undoubtedly, other 
surgeons may use different instrumentation (i.e. the traction table for the 
anterior approach), or approach the hip differently than the steps outlined in our 
study. Another limitation is that the cost data is also presented using a small 
sample of patients with hip arthritis. Operating room time and length of stay in 
hospital may vary for other primary diagnoses, such as inflammatory 
arthropathy, post-traumatic arthritis, or developmental dysplasia of the hip. 
Finally, physiotherapy assessments and treatment was unblinded. This could 
have introduced expectation bias, thus influencing length of stay in hospital. 
However, weight-bearing status and discharge milestones were standardized 
as per our institution’s discharge pathway. 
 
Our study has several strengths. To our knowledge, this is the first study 
examining the impact surgical approach has on costs associated with THA. The 
prospective, micro-costing method ensured that cost data was captured 
accurately. Our hopes are that this study can then stand as a reference for 
gross-costing analyses in future cost-effectiveness analyses. Standardizing the 
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implants, and thus standardizing the cost of the implants, eliminated the 
tremendous variability in implant costs from influencing the results 17. Other 
institutions can then infer the impact on implant costs on their overall costs, 
assuming the other variables (operating room and inpatient costs) are similar. 
The detailed analysis regarding intra-operative time and inpatient length of stay 
will help decision makers determine where they can invest resources in order to 
improve cost-savings within their own institution. 
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4.5 Conclusion 
This study examined the impact of surgical approach on costs in patients 
undergoing THA. The anterior approach group demonstrated significantly 
reduced overall costs compared to a lateral and posterior approach cohort. The 
cost-savings were largely amassed through a significant reduction in hospital 
length of stay. The micro-costing method provided an accurate estimation of 
THA costs from within a Canadian institution. Future studies should examine 
the impact of surgical approach on outpatient costs from a societal perspective, 
and combine effectiveness measures in a formal cost-effectiveness analysis.  
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Chapter 5 
5 General discussion and conclusions 
The choice of surgical approach for total hip arthroplasty (THA) is an area of 
debate amongst orthopaedic surgeons. The distribution of surgical approach 
used for THA varies not only in Canada, but internationally 1, 2. Several studies 
have sought to elicit the impact of surgical approach on clinical outcomes in 
THA with mixed methodologies. There is also a paucity of literature examining 
any financial implications of utilizing a particular surgical approach for THA from 
a hospital perspective. Thus, the objectives of this thesis were: 
 
1. To compare various disease-specific and generic clinical outcome 
measures across the three commonest surgical approaches for THA. 
2. To explore the impact of surgical approach on costs for THA. 
 
Accordingly, our hypotheses were: 
 
1. There will be no significant differences between the approaches across 
various clinical outcome measures at short-term follow-up. 
2. There will be no significant differences in total costs from a hospital 
perspective dependent on which surgical approach was used for THA. 
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5.1 Surgical approach in total hip arthroplasty: The impact 
on short-term patient outcomes (Chapter 3) 
 
This study examined the effect of surgical approach on a series of validated 
disease-specific and generic clinical outcome measures. We hypothesized that 
there would be no differences between the surgical approach at short-term 
follow-up. The results of the study rejected the hypothesis for the functional 
score of the Western Ontario and McMaster Osteoarthritis Index (WOMAC) 
questionnaire, and the usual activities dimension of the EQ-5D, at 6-weeks 
follow-up. The posterior approach also outperformed the lateral approach on 
the functional composite score of the Harris hip score (HHS). All other clinical 
outcome comparisons did not demonstrate statistical significance. 
 
Several theories exist as to why the anterior approach may provide an earlier 
functional benefit over other surgical approaches. Commonly cited reasons 
include “muscle-sparing” intervals and reduced post-operative pain 3-6. 
However, cadaveric studies have demonstrated that muscle damage is 
sustained during an anterior approach 7. Additionally, our study did not 
demonstrate any significant differences in the pain composite scores across 
any of the outcome measures. It may be that the abductor tenotomy performed 
during a lateral approach produces enough abductor dysfunction to complicate 
some functional activities in the early post-operative course. This may explain 
why the posterior approach, which spares the abductor complex, outperformed 
the lateral approach on a functional composite score. In the future, dynamic 
kinematic studies can be used to demonstrate biomechanical differences during 
routine daily activities such as stairs and gait. 
 
Attention needs to be given to the significantly higher complication rate 
observed in the anterior approach cohort. Injury to the lateral femoral cutaneous 
nerve resulted in symptomatic paresthesias in 17.5% of patients undergoing a 
THA through an anterior approach. Fortunately, injury to the nerve seemingly 
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has no impact on clinical outcome scores following THA. This is likely because 
of the nerve’s purely sensory innervation, resulting in no motor deficits and 
functional compromise following injury, and that the disease-specific outcome 
measures do not address nervous paresthesias in any of their questions. 
However, it is important that patients are made aware of this potential 
complication during informed consent, as complication rates of 17.5% are 
usually unacceptably high. 
 
This prospective study demonstrated that there are clinical differences across 
the 3 main surgical approaches for THA. To our knowledge, it is the first study 
comparing these 3 approaches using standardized implants, the importance of 
which cannot be understated.  
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5.2 Surgical approach in total hip arthroplasty: A cost- 
 analysis (Chapter 4) 
 
This study examined the impact of surgical approach on costs for THA from a 
hospital perspective. To our knowledge, this is the first study of its kind 
performing a cost-analysis on surgical approach in THA. Previous cost-
analyses from Canadian institutions used retrospective, database data to 
acquire costs for THA 8. The prospective, micro-costing method used in this 
study provided accurate data that will prove useful in future cost-effectiveness 
analyses. 
 
We were able to reject the hypothesis that there would be no cost differences 
between the 3 surgical approaches following THA. The anterior approach 
demonstrated significantly reduced overall costs from a hospital perspective. 
Despite increased procedural costs, the anterior approach reduces overall costs 
by significantly shortening hospital length of stay. 
 
In order to reduce costs associated with operative procedures, hospital 
administrators should examine the operating room and hospital stay as two 
separate entities. The majority of the overall costs were incurred through the 
cost of the procedure. Improving operating room efficiency through the use of 
designated operating room units has been suggested 9. Surgical and anesthetic 
expertise, competent support staff, and reducing patient turnover are all 
principles of this concept. The use of accelerated rehabilitation protocols and 
having adequate outpatient resources to support earlier hospital discharges are 
important considerations 10. 
 
The use of a labour-intense, micro-costing method has provided accurate cost 
data comparing surgical approach for THA. Although the generalizability of the 
data can be questioned, the principles of cost reduction remain the same, as 
variables such as operating room time and length of stay in hospital are 
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universal. Future directions include capturing outpatient cost data with long-
term effectiveness measures (i.e. quality-adjusted life years) in order to perform 
a cost-effectiveness analysis from a societal perspective. 
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5.3 Conclusions 
Total hip arthroplasty continues to be the cornerstone treatment modality for 
painful and functionally debilitating hip arthritis. The procedure produces 
tremendous clinically important differences in patient reported pain, function, 
and mental health, regardless of surgical approach. The choice of surgical 
approach can have a significant impact on patient reported functional 
outcomes, and costs from a hospital perspective.  
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Appendix A: Glossary of terms 
 
Abduction   Movement away from the center of the body 
 
Abductor insufficiency Weak abductor muscles around the hip causing 
    either pain or changes in function and gait 
 
Adduction   Movement towards the center of the body 
 
Anteversion   Anatomic reference to something that is directed 
    forward, or anteriorly 
 
Arthropathy   Any condition causing articular cartilage damage 
    resulting in joint arthritis 
 
Arthroplasty   A surgical procedure where the articular surface of a 
    joint is replaced by some other tissue or substance 
 
Articulation   Contact made between two surfaces covered by 
    articular cartilage 
 
Capsulotomy   Incising through a joint capsule 
 
Coronal   A vertical plane dividing the body into a front and 
    back section 
 
Cost-analysis  Determining the costs and financial risks and  
    benefits of undergoing an intervention or procedure 
 
Distal    Spatial relationship away from the trunk of the body 
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Extension   A straightening motion between two body parts that 
    increases an angle formed by those two parts 
 
External rotation  Rotation away from the center of the body 
 
Flexion   A bending motion between two body parts that  
    decreases an angle formed by those two parts 
 
Fluoroscopy   The use of x-rays during a procedure 
 
Idiopathic   Unknown pathogenesis of a disease process 
 
Insertion   The more distal attachment site of a muscle or  
    ligament 
 
Internal rotation  Rotation towards the center of the body 
 
Interval   In surgery, refers to a plane between the fascia of 
    two different muscles, typically innervated by  
    different nerves 
 
Lateral   Away from the body’s midline 
 
Lateral decubitus  Patient position during surgery when they lie on their 
    side 
 
Medial   Closer to the body’s midline 
 
Micro-costing  A method of acquiring costs of health resources that 
    involves attaching an exact cost to a resource  
    consumed during an intervention 
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Muscle-sparing  Surgery that involves minimal dissection of muscular 
    tissue 
 
Neuropraxia   Injury to a nerve resulting in temporary loss of  
    sensation or motor function supplied by that nerve 
 
Origin    The more proximal attachment site of a muscle or 
    ligament 
 
Osteophytosis  Formation of osteophytes, or irregular bony  
    prominences, as a consequence of arthritis 
 
Osteotomy   Surgical cutting or removal of bone 
 
Paresthesia   Sensory change, often describes as tingling or “pins-
    and-needles”, in the distribution of a nerve due to 
    injury or degeneration 
 
Perspective   The targeted audience of a cost-analysis 
 
Peri-prosthetic  Occurring around a prosthesis used during a joint 
    replacement 
 
Proximal   Spatial relationship towards the trunk of the body 
 
Retroversion   Anatomical reference to something that is directed 
    backward, or posteriorly 
 
Sagittal   A vertical plane dividing the body into a right and left 
    half 
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Subchondral cyst  A fluid-filled sac underlying a joint surface due to 
    arthritis 
 
Subchondral sclerosis Thickening and hardening of the bone underlying 
    articular cartilage due to arthritis 
 
Surgical approach  Soft tissue dissection and working between inter-
    nervous or inter-muscular planes in order to reach a 
    specific anatomic location (i.e. the hip joint) 
 
Synovial joint   Articulation between two bones covered by articular 
    cartilage and encapsulated by a joint capsule filled 
    with synovial fluid 
 
Tenotomy   Incising through or releasing a tendon from its  
    insertion 
 
Transverse   A horizontal plane dividing the body into an upper
    and lower section 
 
Trendelenburg gait/sign A gait pattern / physical exam finding due to weak 
    abductor muscles where the center of gravity is 
    shifted away from the affected leg to reduce load on 
    the abductor muscles 
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Appendix B: Abbreviations list 
 
ACR    American College of Rheumatology 
 
ANOVA   Analysis of variance 
 
BL    Brent Lanting 
 
BMI    Body mass index 
 
CK    Creatine kinase 
 
CRP    C-reactive protein 
 
ESR    Erythrocyte sedimentation rate 
 
EV    Edward Vasarhelyi 
 
FAI    Femoroacetabular impingement 
 
HHS    Harris hip score 
 
ICER    Incremental cost-effectiveness ratio 
 
JH    James Howard 
 
LHSC    London Health Sciences Centre 
 
MCS    Mental component summary 
 
MID    Minimally important difference 
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MRI    Magnetic resonance imaging 
 
NSAID   Non-steroidal anti-inflammatory drug 
 
PACU    Post-anesthetic care unit 
 
PCS    Physical component summary 
 
QALY    Quality-adjusted life year 
 
RCT    Randomized-controlled trial 
 
SDC    Smallest detectable change 
 
SEM    Standard error of measurement 
 
SF-12    Short-form 12 questionnaire 
 
THA    Total hip arthroplasty 
 
TUG    Timed up-and-go test 
 
US    United States 
 
VAS    Visual analogue scale 
 
WOMAC   Western Ontario and McMaster Osteoarthritis Index 
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Appendix C: In-hospital Stay Data Collection Sheet 
 
Surgical approach in total hip arthroplasty: Patient outcomes and impact 
on costs 
In-hospital Stay Data Collection Sheet 
 
Patient PIN:  
Surgeon: 
JH                   EV                         BL    
Date of Surgery (DD/MM/YYYY):  
Date and Time of Admission 
(DD/MM/YYYY, HH:MM): 
 
Date and Time of Discharge 
(DD/MM/YYYY, HH:MM): 
 
 
Hospital Investigations: 
 
Investigation Number of 
Tests 
Date of Test (i.e. POD 
1, 2, 3, etc.) 
Other 
Information 
(i.e. +’ve/-‘ve 
US, CT-PA to 
r/o PE) 
CBC    
Lytes    
BUN/Cr    
Extended Lytes    
Albumin    
LFTs    
CK/Trops    
Thyroid (TSH)    
Chest X-ray    
Abdo X-ray    
CT scan (chest, abdo, pelvis)    
Lower extremity Doppler U/S    
Urine R&M, C&S    
ECG    
Echocardiogram    
Pelvis X-ray / Hip X-ray    
Other:    
Other:    
Other:    
Other:    
 
Blood Transfusions:  Yes  No   Number:     
 
 
 
In-hospital Consultations: 
 
Consulting Service Date of Consult Number of 
Assessments 
Intervention (i.e. 
additional surgery, 
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ICU admit, scope) 
Internal Medicine    
Acute Pain Service (APS)    
Critical Care Team (CCOT)    
Gastroenterology (GI)    
General Surgery    
Other:    
Other:    
Other:    
Other:    
 
Allied-health Assessments: 
 
Consulting Service Date of Consult Number of 
Assessments 
Intervention 
(i.e. fit for 
walker/crutches, 
home 
adjustments by 
OT, dressing 
changes/home 
PT through 
CCAC, etc.) 
Physiotherapy    
Occupational Therapy    
Social Work    
CCAC    
Other:    
Other:    
 
Dressing Changes: 
 
Type of Dressing (i.e. Tegaderm, gauze) Number of Dressing Changes 
  
  
  
 
 
Complications: 
 
Complication Date of 
Complication 
Intervention (i.e. antibiotics and for how 
long, surgery, medication, etc.) 
Urinary tract infection   
Deep vein thrombosis   
Pulmonary embolism   
Pneumonia   
Wound infection   
Peri-prosthetic fracture   
Dislocated hip   
Nerve Palsy   
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Urinary Retention (i.e. foley 
catheter/in-and-out) 
  
Other:   
Other:   
Other:   
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Appendix D: Summary of implant selection 
 
Study 
No. 
Surgical 
Approach Acetabular Implant Femoral stem Implant 
1 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard, Collared 
2 Anterior DePuy 60mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 15 Coxa Vara Lateralized 
3 Anterior DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
22 Anterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
24 Anterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Coxa Vara Lateralized 
27 Anterior DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
30 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
31 Anterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
32 Anterior DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
34 Anterior DePuy 60mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 14 Coxa Vara Lateralized 
35 Anterior DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Coxa Vara Lateralized 
36 Anterior DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
37 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Coxa Vara Lateralized 
42 Anterior DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
51 Anterior DePuy 62mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 15 Coxa Vara Lateralized 
59 Anterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
60 Anterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Coxa Vara Lateralized 
68 Anterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
70 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
79 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Coxa Vara Lateralized 
80 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Coxa Vara Lateralized 
87 Anterior DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
88 Anterior DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Standard Collared 
94 Anterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Standard Collared 
95 Anterior DePuy 60mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 14 Standard Collared 
103 Anterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
104 Anterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
105 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
107 Anterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Coxa Vara Lateralized 
113 Anterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Coxa Vara Lateralized 
116 Anterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Standard Collared 
132 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Coxa Vara Lateralized 
138 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
142 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
146 Anterior DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Coxa Vara Lateralized 
154 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
156 Anterior DePuy 48mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
157 Anterior DePuy 48mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
167 Anterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
172 Anterior DePuy 64mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Coxa Vara Lateralized 
5 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Standard Collared 
10 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Coxa Vara Lateralized 
11 Posterior DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
14 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
17 Posterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
20 Posterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
33 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Coxa Vara Lateralized 
41 Posterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Standard Collared 
43 Posterior DePuy 64mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
45 Posterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
46 Posterior DePuy 60mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
48 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Standard Collared 
52 Posterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
53 Posterior DePuy 60mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Coxa Vara Lateralized 
54 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
55 Posterior DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
58 Posterior DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
71 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Coxa Vara Lateralized 
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75 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
76 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Standard Collared 
98 Posterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Coxa Vara Lateralized 
120 Posterior DePuy 62mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
137 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
139 Posterior DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
147 Posterior DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Coxa Vara Lateralized 
150 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
155 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Standard Collared 
159 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
161 Posterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Standard Collared 
162 Posterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Coxa Vara Lateralized 
166 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
168 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
173 Posterior DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Coxa Vara Lateralized 
176 Posterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Coxa Vara Lateralized 
177 Posterior DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
178 Posterior DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
128 Posterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Coxa Vara Lateralized 
129 Posterior DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
6 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
9 Lateral DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
12 Lateral DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
15 Lateral DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
19 Lateral DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Standard Collared 
23 Lateral DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Standard Collared 
25 Lateral DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
29 Lateral DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
38 Lateral DePuy 64mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
47 Lateral DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Coxa Vara Lateralized 
49 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
61 Lateral DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
62 Lateral DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
63 Lateral DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
64 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Standard Collared 
65 Lateral DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
66 Lateral DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 9 Standard Collared 
67 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
72 Lateral DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
73 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
77 Lateral DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Coxa Vara Lateralized 
81 Lateral DePuy 56mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
89 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
90 Lateral DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Standard Collared 
91 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
92 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
93 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
99 Lateral DePuy 50mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 8 Standard Collared 
100 Lateral DePuy 64mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Standard Collared 
101 Lateral DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
102 Lateral DePuy 60mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Coxa Vara Lateralized 
106 Lateral DePuy 60mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
112 Lateral DePuy 60mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 13 Standard Collared 
114 Lateral DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Coxa Vara Lateralized 
117 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 12 Standard Collared 
123 Lateral DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
130 Lateral DePuy 54mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
131 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 10 Standard Collared 
140 Lateral DePuy 58mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
144 Lateral DePuy 52mm Pinnacle Sector II Acetabular Cup DePuy Corail Size 11 Standard Collared 
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Study 
No. 
Surgical 
Approach Femoral head Implant Polyethylene Implant 
1 Anterior DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome  DePuy 32mm Pinnacle Altrx Liner 
2 Anterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
3 Anterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
22 Anterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
24 Anterior DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
27 Anterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
30 Anterior DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome  DePuy 32mm Pinnacle Altrx Liner 
31 Anterior 
DePuy 36mm, Minus 2.0 Articuleze Cobalt 
Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
32 Anterior DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
34 Anterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
35 Anterior DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
36 Anterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
37 Anterior DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
42 Anterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
51 Anterior 
DePuy 36mm, Minus 2.0 Articuleze Cobalt 
Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
59 Anterior DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
60 Anterior DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
68 Anterior DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
70 Anterior 
DePuy 36mm, Minus 2.0 Articuleze Cobalt 
Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
79 Anterior DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
80 Anterior DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome  DePuy 32mm Pinnacle Altrx Liner 
87 Anterior 
DePuy 36mm, Minus 2.0 Articuleze Cobalt 
Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
88 Anterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
94 Anterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
95 Anterior DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
103 Anterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
104 Anterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
105 Anterior DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
107 Anterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner, 10 Degree 
113 Anterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
116 Anterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome  DePuy 36mm Plus 4 Pinnacle Altrx Liner 
132 Anterior DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
138 Anterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
142 Anterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
146 Anterior DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
154 Anterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
156 Anterior DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
157 Anterior DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
167 Anterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
172 Anterior 
DePuy 36mm, Minus 2.0 Articuleze Cobalt 
Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
5 Posterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
10 Posterior DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
11 Posterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
14 Posterior DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
17 Posterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
20 Posterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 54mm Pinnacle Altrx Liner 
33 Posterior DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
41 Posterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
43 Posterior DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
45 Posterior DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
46 Posterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
48 Posterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
52 Posterior DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome  DePuy 32mm Plus 4 Pinnacle Altrx Liner 
53 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome  DePuy 36mm Plus 4 Pinnacle Altrx Liner 
54 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome  DePuy 36mm Pinnacle Altrx Liner 
55 Posterior DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
58 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
71 Posterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
75 Posterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
76 Posterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
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98 Posterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
120 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
137 Posterior DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
139 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome  DePuy 36mm Pinnacle Altrx Liner 
147 Posterior DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
150 Posterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
155 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
159 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
161 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
162 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
166 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
168 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
173 Posterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner, 10 Degree 
176 Posterior DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
177 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
178 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
128 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
129 Posterior DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome  DePuy 36mm Pinnacle Altrx Liner 
6 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
9 Lateral DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
12 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
15 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
19 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
23 Lateral DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
25 Lateral DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
29 Lateral DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome  DePuy 36mm Plus 4 Pinnacle Altrx Liner 
38 Lateral DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
47 Lateral DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Plus 4 Pinnacle Altrx Liner 
49 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
61 Lateral DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
62 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
63 Lateral DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome  DePuy 32mm Pinnacle Altrx Liner 
64 Lateral DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome  DePuy 32mm Pinnacle Altrx Liner 
65 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
66 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
67 Lateral DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
72 Lateral DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
73 Lateral DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
77 Lateral DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
81 Lateral DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
89 Lateral DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome DePuy 32mm Plus 4 Pinnacle Altrx Liner 
90 Lateral DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
91 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
92 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
93 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
99 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
100 Lateral DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
101 Lateral DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
102 Lateral DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
106 Lateral DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
112 Lateral DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
114 Lateral DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 36mm Pinnacle Altrx Liner 
117 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
123 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
130 Lateral DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome  DePuy 32mm Pinnacle Altrx Liner 
131 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
140 Lateral DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
144 Lateral DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome DePuy 32mm Pinnacle Altrx Liner 
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Appendix E: Summary of intra-operative costs 
 
Study No.   Time of Fluoroscopy (s)   Volume of irrigation per case 
Surgical Approach   Procedure Time (min)   Cost of irrigation 
Surgeon   
Cost per min Fluoro machine and 
technician   
Surgery Date   Radiology Cost to read Xray   Type and Number of sutures 
Operative Side   Cost of fluoroscopy   Cost of sutures 
Primary Diagnosis     
  Cautery   Type of post-op dressing 
Procedure Time (min)   Cost of cautery   Cost of dressings 
Total Time in OR (min)     
Direct cost per min OR   Number of blood transfusions   Tubing 
Indirect cost per min OR   Cost of blood transfusion   Cost of tubing 
Total cost per min OR     
Total Cost OR time   Cement used? yes=1, no=0   Wraps 
  Cost of cement   Cost of coban wrap 
Patient Set-up Time (min)     
Turnover time (min)     Drape type 
  Acetabular Implant   Cost of drapes 
Type of anesthesia   Cost of acetabular implant   
Spinal ($)     Type of saw blade 
Total anesthesia time   Femoral stem Implant   Cost of saw blade 
Time Units   Cost of femoral stem   
Basic Units (THA)     Type of Linen 
Total Cost Anaesthesia   Femoral head Implant   Cost of linen 
  Cost of femoral head   
Type of Local Anesthetic and Volume     Type of sponge 
Cost of local anesthesia   Polyethylene Implant   Cost of sponge 
  Cost of Polyethylene   
Foley catheter 1=yes, 0=no     Gloves 
Cost of Foley   Other Implant (s) - screws, wires   Cost of gloves 
  Cost of other implants   
Type of Surgical prep     OHIP cost of THA 
Cost of prep   Cost per case for Hana Table   
  Cost per case for lead gowns   Grand Total Cost of Procedure 
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Appendix F: Summary of costs acquired for in-hospital stay 
Study No.   Number of blood transfusions   HbA1c tests 
Approach   Cost per transfusion   Cost per test 
Surgery Date   Cost of transfusions   Cost of HbA1c tests 
Date of Admission, HH:MM     
Date of Discharge, HH:MM   CBC tests   Abxr Tests 
Length of Stay (hrs)   Cost per test   Cost per test 
Total PACU time (h)   Cost of CBC   Cost of Abxr tests 
Total PACU time (min)     
Direct cost per min   Lyte Tests   CT thorax tests 
Indirect cost per min   Cost per test   Cost per test 
Total cost per min PACU   Cost of lyte tests   Cost of CT thorax tests 
Total Cost PACU     
  LFTs   CT Abdo-pelvis tests 
Total OR Time (min)   Cost per test   Cost per test 
Total OR Time (h)   Cost of LFT   Cost of CT Abdo-pelvis tests 
    
Total inpatient time (h)   BUN/Cr tests   CT hip tests 
Total cost per hour   Cost per test   Cost per test 
Total cost of meals   Cost of BUN/Cr tests   Cost of CT hips tests 
Total Cost Inpatient Time     
  CK/trop tests   ECG 
Number of min Physiotherapy   Cost per test   Cost per test 
Cost per min Physiotherapy   Cost of CK/Trop tests   Costs of ECG 
Cost of Physiotherapy     
  Arterial Gas tests   Bilateral US 
Number of min Social Work   Cost per test   Cost per test 
Cost per min Social work   Cost of Arterial gases   Cost of Bilateral US 
Cost of Social work     
  INR/PTT tests   Knee XR 
Internal Medicine (Consult, assessment)   Cost per test   Cost per test 
Acute pain service (Consult, assessment)   Cost of INR/PTT tests   Cost of Knee XR 
Gastroenterology (Consult, assessment)     
Infectious diseases (Consult, assessment)   Albumin tests   Echo 
Hematology (Consult, assessment)   Cost per test   Cost per test 
Other (Consult, assessment)   Cost of albumin tests   Cost of Echo 
Total cost of consultations     
  TSH tests   AP hip XR 
Number of min OT   Cost per test   Cost per test 
Cost per min OT   Cost of TSH tests   Costs of AP hip XR 
Cost of OT     
  Urine R/M, C/S   Unilateral U/s 
  Cost of Urine R/M, C/s   Cost per test 
    Cost of unilateral US 
  Foley Catheter    
  Cost per insertion   Post op Abx 
  Cost of Foley Catheter   Cost per Dose 
    # of doses 
  AP Pelvis   Cost of Abx 
  Cost per test   
  Cost of AP Pelvis   DVT prophylaxis 
    Cost per dose 
  CXR tests   # of doses 
  Cost per test   Cost of DVT prophylaxis 
  Cost of CXR tests   
    Other costs 
  Ext Lyte Test   
  Cost per test   
Grand Total Inpatient 
Costs 
  Cost of Ext Lyte Tests   
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